company_name,company_ticker,company_lei,company_cik,year,quarter,start_date,end_date,filing_date,parent,tag,financial_name,factor,balance,unit,value
PTC Therapeutics Inc,PTCT,549300UJLWOIWFDGB318,0001070081,2012.0,Q2,2012-04-01,2012-06-30,2013-08-13 08:30:44+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,7585177.0
PTC Therapeutics Inc,PTCT,549300UJLWOIWFDGB318,0001070081,2012.0,Q2,2012-04-01,2012-06-30,2013-08-13 08:30:44+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,7585177.0
PTC Therapeutics Inc,PTCT,549300UJLWOIWFDGB318,0001070081,2012.0,Q2,2012-04-01,2012-06-30,2013-08-13 08:30:44+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,7585177.0
PTC Therapeutics Inc,PTCT,549300UJLWOIWFDGB318,0001070081,2012.0,Q2,2012-04-01,2012-06-30,2013-08-13 08:30:44+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,3164385.0
PTC Therapeutics Inc,PTCT,549300UJLWOIWFDGB318,0001070081,2012.0,Q2,2012-04-01,2012-06-30,2013-08-13 08:30:44+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,11918999.0
PTC Therapeutics Inc,PTCT,549300UJLWOIWFDGB318,0001070081,2012.0,Q2,2012-04-01,2012-06-30,2013-08-13 08:30:44+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,15083384.0
PTC Therapeutics Inc,PTCT,549300UJLWOIWFDGB318,0001070081,2012.0,Q2,2012-04-01,2012-06-30,2013-08-13 08:30:44+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-7498207.0
PTC Therapeutics Inc,PTCT,549300UJLWOIWFDGB318,0001070081,2012.0,Q2,2012-04-01,2012-06-30,2013-08-13 08:30:44+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,-335081.0
PTC Therapeutics Inc,PTCT,549300UJLWOIWFDGB318,0001070081,2012.0,Q2,2012-04-01,2012-06-30,2013-08-13 08:30:44+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-335081.0
PTC Therapeutics Inc,PTCT,549300UJLWOIWFDGB318,0001070081,2012.0,Q2,2012-04-01,2012-06-30,2013-08-13 08:30:44+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-7833288.0
PTC Therapeutics Inc,PTCT,549300UJLWOIWFDGB318,0001070081,2012.0,Q2,2012-04-01,2012-06-30,2013-08-13 08:30:44+00:00,netincomecontinuing,othergains,"Other Gains / (Losses), net",+,credit,usd,1765216.0
PTC Therapeutics Inc,PTCT,549300UJLWOIWFDGB318,0001070081,2012.0,Q2,2012-04-01,2012-06-30,2013-08-13 08:30:44+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-6068072.0
PTC Therapeutics Inc,PTCT,549300UJLWOIWFDGB318,0001070081,2012.0,Q2,2012-04-01,2012-06-30,2013-08-13 08:30:44+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-6068072.0
PTC Therapeutics Inc,PTCT,549300UJLWOIWFDGB318,0001070081,2012.0,Q2,2012-04-01,2012-06-30,2013-08-13 08:30:44+00:00,netincometocommon,preferreddividends,Preferred Stock Dividends Declared,-,debit,usd,377787.0
PTC Therapeutics Inc,PTCT,549300UJLWOIWFDGB318,0001070081,2012.0,Q2,2012-04-01,2012-06-30,2013-08-13 08:30:44+00:00,netincometocommon,otheradjustmentstonetincometocommon,Other Adjustments to Net Income / (Loss) Attributable to Common Shareholders),-,debit,usd,-159954069.0
PTC Therapeutics Inc,PTCT,549300UJLWOIWFDGB318,0001070081,2012.0,Q2,2012-04-01,2012-06-30,2013-08-13 08:30:44+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,153508210.0
PTC Therapeutics Inc,PTCT,549300UJLWOIWFDGB318,0001070081,2012.0,Q2,2012-04-01,2012-06-30,2013-08-13 08:30:44+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,3091.0
PTC Therapeutics Inc,PTCT,549300UJLWOIWFDGB318,0001070081,2012.0,Q2,2012-04-01,2012-06-30,2013-08-13 08:30:44+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,168.0
PTC Therapeutics Inc,PTCT,549300UJLWOIWFDGB318,0001070081,2012.0,Q2,2012-04-01,2012-06-30,2013-08-13 08:30:44+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,10753.0
PTC Therapeutics Inc,PTCT,549300UJLWOIWFDGB318,0001070081,2012.0,Q2,2012-04-01,2012-06-30,2013-08-13 08:30:44+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,48.29
PTC Therapeutics Inc,PTCT,549300UJLWOIWFDGB318,0001070081,2012.0,Q2,2012-04-01,2012-06-30,2013-08-13 08:30:44+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,900000.0
PTC Therapeutics Inc,PTCT,549300UJLWOIWFDGB318,0001070081,2012.0,Q2,2012-04-01,2012-06-30,2013-08-13 08:30:44+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,168.0
PTC Therapeutics Inc,PTCT,549300UJLWOIWFDGB318,0001070081,2012.0,Q3,2012-07-01,2012-09-30,2013-11-14 16:18:28+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,7195076.0
PTC Therapeutics Inc,PTCT,549300UJLWOIWFDGB318,0001070081,2012.0,Q3,2012-07-01,2012-09-30,2013-11-14 16:18:28+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,7195076.0
PTC Therapeutics Inc,PTCT,549300UJLWOIWFDGB318,0001070081,2012.0,Q3,2012-07-01,2012-09-30,2013-11-14 16:18:28+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,7195076.0
PTC Therapeutics Inc,PTCT,549300UJLWOIWFDGB318,0001070081,2012.0,Q3,2012-07-01,2012-09-30,2013-11-14 16:18:28+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,3783929.0
PTC Therapeutics Inc,PTCT,549300UJLWOIWFDGB318,0001070081,2012.0,Q3,2012-07-01,2012-09-30,2013-11-14 16:18:28+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,10466454.0
PTC Therapeutics Inc,PTCT,549300UJLWOIWFDGB318,0001070081,2012.0,Q3,2012-07-01,2012-09-30,2013-11-14 16:18:28+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,14250383.0
PTC Therapeutics Inc,PTCT,549300UJLWOIWFDGB318,0001070081,2012.0,Q3,2012-07-01,2012-09-30,2013-11-14 16:18:28+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-7055307.0
PTC Therapeutics Inc,PTCT,549300UJLWOIWFDGB318,0001070081,2012.0,Q3,2012-07-01,2012-09-30,2013-11-14 16:18:28+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,-247325.0
PTC Therapeutics Inc,PTCT,549300UJLWOIWFDGB318,0001070081,2012.0,Q3,2012-07-01,2012-09-30,2013-11-14 16:18:28+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-247325.0
PTC Therapeutics Inc,PTCT,549300UJLWOIWFDGB318,0001070081,2012.0,Q3,2012-07-01,2012-09-30,2013-11-14 16:18:28+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-7302632.0
PTC Therapeutics Inc,PTCT,549300UJLWOIWFDGB318,0001070081,2012.0,Q3,2012-07-01,2012-09-30,2013-11-14 16:18:28+00:00,netincomecontinuing,othergains,"Other Gains / (Losses), net",+,credit,usd,5507.0
PTC Therapeutics Inc,PTCT,549300UJLWOIWFDGB318,0001070081,2012.0,Q3,2012-07-01,2012-09-30,2013-11-14 16:18:28+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-7297125.0
PTC Therapeutics Inc,PTCT,549300UJLWOIWFDGB318,0001070081,2012.0,Q3,2012-07-01,2012-09-30,2013-11-14 16:18:28+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-7297125.0
PTC Therapeutics Inc,PTCT,549300UJLWOIWFDGB318,0001070081,2012.0,Q3,2012-07-01,2012-09-30,2013-11-14 16:18:28+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-7297125.0
PTC Therapeutics Inc,PTCT,549300UJLWOIWFDGB318,0001070081,2012.0,Q3,2012-07-01,2012-09-30,2013-11-14 16:18:28+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,4545.0
PTC Therapeutics Inc,PTCT,549300UJLWOIWFDGB318,0001070081,2012.0,Q3,2012-07-01,2012-09-30,2013-11-14 16:18:28+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-1605.53
PTC Therapeutics Inc,PTCT,549300UJLWOIWFDGB318,0001070081,2012.0,Q3,2012-07-01,2012-09-30,2013-11-14 16:18:28+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,4545.0
PTC Therapeutics Inc,PTCT,549300UJLWOIWFDGB318,0001070081,2012.0,Q3,2012-07-01,2012-09-30,2013-11-14 16:18:28+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-1605.53
PTC Therapeutics Inc,PTCT,549300UJLWOIWFDGB318,0001070081,2012.0,Q3,2012-07-01,2012-09-30,2013-11-14 16:18:28+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,0.0
PTC Therapeutics Inc,PTCT,549300UJLWOIWFDGB318,0001070081,2012.0,Q3,2012-07-01,2012-09-30,2013-11-14 16:18:28+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-1605.53
PTC Therapeutics Inc,PTCT,549300UJLWOIWFDGB318,0001070081,2013.0,Q1,2013-01-01,2013-03-31,2014-05-06 17:11:30+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,7142000.0
PTC Therapeutics Inc,PTCT,549300UJLWOIWFDGB318,0001070081,2013.0,Q1,2013-01-01,2013-03-31,2014-05-06 17:11:30+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,7142000.0
PTC Therapeutics Inc,PTCT,549300UJLWOIWFDGB318,0001070081,2013.0,Q1,2013-01-01,2013-03-31,2014-05-06 17:11:30+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,7142000.0
PTC Therapeutics Inc,PTCT,549300UJLWOIWFDGB318,0001070081,2013.0,Q1,2013-01-01,2013-03-31,2014-05-06 17:11:30+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,4461000.0
PTC Therapeutics Inc,PTCT,549300UJLWOIWFDGB318,0001070081,2013.0,Q1,2013-01-01,2013-03-31,2014-05-06 17:11:30+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,11257000.0
PTC Therapeutics Inc,PTCT,549300UJLWOIWFDGB318,0001070081,2013.0,Q1,2013-01-01,2013-03-31,2014-05-06 17:11:30+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,15718000.0
PTC Therapeutics Inc,PTCT,549300UJLWOIWFDGB318,0001070081,2013.0,Q1,2013-01-01,2013-03-31,2014-05-06 17:11:30+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-8576000.0
PTC Therapeutics Inc,PTCT,549300UJLWOIWFDGB318,0001070081,2013.0,Q1,2013-01-01,2013-03-31,2014-05-06 17:11:30+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,-6162000.0
PTC Therapeutics Inc,PTCT,549300UJLWOIWFDGB318,0001070081,2013.0,Q1,2013-01-01,2013-03-31,2014-05-06 17:11:30+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,54000.0
PTC Therapeutics Inc,PTCT,549300UJLWOIWFDGB318,0001070081,2013.0,Q1,2013-01-01,2013-03-31,2014-05-06 17:11:30+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-6108000.0
PTC Therapeutics Inc,PTCT,549300UJLWOIWFDGB318,0001070081,2013.0,Q1,2013-01-01,2013-03-31,2014-05-06 17:11:30+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-14684000.0
PTC Therapeutics Inc,PTCT,549300UJLWOIWFDGB318,0001070081,2013.0,Q1,2013-01-01,2013-03-31,2014-05-06 17:11:30+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-14684000.0
PTC Therapeutics Inc,PTCT,549300UJLWOIWFDGB318,0001070081,2013.0,Q1,2013-01-01,2013-03-31,2014-05-06 17:11:30+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-14684000.0
PTC Therapeutics Inc,PTCT,549300UJLWOIWFDGB318,0001070081,2013.0,Q1,2013-01-01,2013-03-31,2014-05-06 17:11:30+00:00,netincometocommon,preferreddividends,Preferred Stock Dividends Declared,-,debit,usd,18249000.0
PTC Therapeutics Inc,PTCT,549300UJLWOIWFDGB318,0001070081,2013.0,Q1,2013-01-01,2013-03-31,2014-05-06 17:11:30+00:00,netincometocommon,otheradjustmentstonetincometocommon,Other Adjustments to Net Income / (Loss) Attributable to Common Shareholders),-,debit,usd,-3391000.0
PTC Therapeutics Inc,PTCT,549300UJLWOIWFDGB318,0001070081,2013.0,Q1,2013-01-01,2013-03-31,2014-05-06 17:11:30+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-29542000.0
PTC Therapeutics Inc,PTCT,549300UJLWOIWFDGB318,0001070081,2013.0,Q1,2013-01-01,2013-03-31,2014-05-06 17:11:30+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,0.0
PTC Therapeutics Inc,PTCT,549300UJLWOIWFDGB318,0001070081,2013.0,Q1,2013-01-01,2013-03-31,2014-05-06 17:11:30+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-6527.3
PTC Therapeutics Inc,PTCT,549300UJLWOIWFDGB318,0001070081,2013.0,Q1,2013-01-01,2013-03-31,2014-05-06 17:11:30+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,0.0
PTC Therapeutics Inc,PTCT,549300UJLWOIWFDGB318,0001070081,2013.0,Q1,2013-01-01,2013-03-31,2014-05-06 17:11:30+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-6527.3
PTC Therapeutics Inc,PTCT,549300UJLWOIWFDGB318,0001070081,2013.0,Q1,2013-01-01,2013-03-31,2014-05-06 17:11:30+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,4526.0
PTC Therapeutics Inc,PTCT,549300UJLWOIWFDGB318,0001070081,2013.0,Q1,2013-01-01,2013-03-31,2014-05-06 17:11:30+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-6527.3
PTC Therapeutics Inc,PTCT,549300UJLWOIWFDGB318,0001070081,2013.0,Q2,2013-04-01,2013-06-30,2014-08-07 16:01:10+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,6854000.0
PTC Therapeutics Inc,PTCT,549300UJLWOIWFDGB318,0001070081,2013.0,Q2,2013-04-01,2013-06-30,2014-08-07 16:01:10+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,6854000.0
PTC Therapeutics Inc,PTCT,549300UJLWOIWFDGB318,0001070081,2013.0,Q2,2013-04-01,2013-06-30,2014-08-07 16:01:10+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,6854000.0
PTC Therapeutics Inc,PTCT,549300UJLWOIWFDGB318,0001070081,2013.0,Q2,2013-04-01,2013-06-30,2014-08-07 16:01:10+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,6595000.0
PTC Therapeutics Inc,PTCT,549300UJLWOIWFDGB318,0001070081,2013.0,Q2,2013-04-01,2013-06-30,2014-08-07 16:01:10+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,14712000.0
PTC Therapeutics Inc,PTCT,549300UJLWOIWFDGB318,0001070081,2013.0,Q2,2013-04-01,2013-06-30,2014-08-07 16:01:10+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,21307000.0
PTC Therapeutics Inc,PTCT,549300UJLWOIWFDGB318,0001070081,2013.0,Q2,2013-04-01,2013-06-30,2014-08-07 16:01:10+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-14453000.0
PTC Therapeutics Inc,PTCT,549300UJLWOIWFDGB318,0001070081,2013.0,Q2,2013-04-01,2013-06-30,2014-08-07 16:01:10+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,-114000.0
PTC Therapeutics Inc,PTCT,549300UJLWOIWFDGB318,0001070081,2013.0,Q2,2013-04-01,2013-06-30,2014-08-07 16:01:10+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-19000.0
PTC Therapeutics Inc,PTCT,549300UJLWOIWFDGB318,0001070081,2013.0,Q2,2013-04-01,2013-06-30,2014-08-07 16:01:10+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-133000.0
PTC Therapeutics Inc,PTCT,549300UJLWOIWFDGB318,0001070081,2013.0,Q2,2013-04-01,2013-06-30,2014-08-07 16:01:10+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-14586000.0
PTC Therapeutics Inc,PTCT,549300UJLWOIWFDGB318,0001070081,2013.0,Q2,2013-04-01,2013-06-30,2014-08-07 16:01:10+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-14586000.0
PTC Therapeutics Inc,PTCT,549300UJLWOIWFDGB318,0001070081,2013.0,Q2,2013-04-01,2013-06-30,2014-08-07 16:01:10+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-14586000.0
PTC Therapeutics Inc,PTCT,549300UJLWOIWFDGB318,0001070081,2013.0,Q2,2013-04-01,2013-06-30,2014-08-07 16:01:10+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-14586000.0
PTC Therapeutics Inc,PTCT,549300UJLWOIWFDGB318,0001070081,2013.0,Q2,2013-04-01,2013-06-30,2014-08-07 16:01:10+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,2600000.0
PTC Therapeutics Inc,PTCT,549300UJLWOIWFDGB318,0001070081,2013.0,Q2,2013-04-01,2013-06-30,2014-08-07 16:01:10+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-5.51
PTC Therapeutics Inc,PTCT,549300UJLWOIWFDGB318,0001070081,2013.0,Q2,2013-04-01,2013-06-30,2014-08-07 16:01:10+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,2600000.0
PTC Therapeutics Inc,PTCT,549300UJLWOIWFDGB318,0001070081,2013.0,Q2,2013-04-01,2013-06-30,2014-08-07 16:01:10+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-5.51
PTC Therapeutics Inc,PTCT,549300UJLWOIWFDGB318,0001070081,2013.0,Q2,2013-04-01,2013-06-30,2014-08-07 16:01:10+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,2648832.0
PTC Therapeutics Inc,PTCT,549300UJLWOIWFDGB318,0001070081,2013.0,Q2,2013-04-01,2013-06-30,2014-08-07 16:01:10+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-5.51
PTC Therapeutics Inc,PTCT,549300UJLWOIWFDGB318,0001070081,2013.0,Q3,2013-07-01,2013-09-30,2014-11-06 16:25:55+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,16289000.0
PTC Therapeutics Inc,PTCT,549300UJLWOIWFDGB318,0001070081,2013.0,Q3,2013-07-01,2013-09-30,2014-11-06 16:25:55+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,16289000.0
PTC Therapeutics Inc,PTCT,549300UJLWOIWFDGB318,0001070081,2013.0,Q3,2013-07-01,2013-09-30,2014-11-06 16:25:55+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,16289000.0
PTC Therapeutics Inc,PTCT,549300UJLWOIWFDGB318,0001070081,2013.0,Q3,2013-07-01,2013-09-30,2014-11-06 16:25:55+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,6679000.0
PTC Therapeutics Inc,PTCT,549300UJLWOIWFDGB318,0001070081,2013.0,Q3,2013-07-01,2013-09-30,2014-11-06 16:25:55+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,13886000.0
PTC Therapeutics Inc,PTCT,549300UJLWOIWFDGB318,0001070081,2013.0,Q3,2013-07-01,2013-09-30,2014-11-06 16:25:55+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,20565000.0
PTC Therapeutics Inc,PTCT,549300UJLWOIWFDGB318,0001070081,2013.0,Q3,2013-07-01,2013-09-30,2014-11-06 16:25:55+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-4276000.0
PTC Therapeutics Inc,PTCT,549300UJLWOIWFDGB318,0001070081,2013.0,Q3,2013-07-01,2013-09-30,2014-11-06 16:25:55+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,27000.0
PTC Therapeutics Inc,PTCT,549300UJLWOIWFDGB318,0001070081,2013.0,Q3,2013-07-01,2013-09-30,2014-11-06 16:25:55+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,27000.0
PTC Therapeutics Inc,PTCT,549300UJLWOIWFDGB318,0001070081,2013.0,Q3,2013-07-01,2013-09-30,2014-11-06 16:25:55+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-4249000.0
PTC Therapeutics Inc,PTCT,549300UJLWOIWFDGB318,0001070081,2013.0,Q3,2013-07-01,2013-09-30,2014-11-06 16:25:55+00:00,netincomecontinuing,othergains,"Other Gains / (Losses), net",+,credit,usd,-37000.0
PTC Therapeutics Inc,PTCT,549300UJLWOIWFDGB318,0001070081,2013.0,Q3,2013-07-01,2013-09-30,2014-11-06 16:25:55+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-4286000.0
PTC Therapeutics Inc,PTCT,549300UJLWOIWFDGB318,0001070081,2013.0,Q3,2013-07-01,2013-09-30,2014-11-06 16:25:55+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-4286000.0
PTC Therapeutics Inc,PTCT,549300UJLWOIWFDGB318,0001070081,2013.0,Q3,2013-07-01,2013-09-30,2014-11-06 16:25:55+00:00,netincometocommon,otheradjustmentstonetincometocommon,Other Adjustments to Net Income / (Loss) Attributable to Common Shareholders),-,debit,usd,130000.0
PTC Therapeutics Inc,PTCT,549300UJLWOIWFDGB318,0001070081,2013.0,Q3,2013-07-01,2013-09-30,2014-11-06 16:25:55+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-4416000.0
PTC Therapeutics Inc,PTCT,549300UJLWOIWFDGB318,0001070081,2013.0,Q3,2013-07-01,2013-09-30,2014-11-06 16:25:55+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,23200000.0
PTC Therapeutics Inc,PTCT,549300UJLWOIWFDGB318,0001070081,2013.0,Q3,2013-07-01,2013-09-30,2014-11-06 16:25:55+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.19
PTC Therapeutics Inc,PTCT,549300UJLWOIWFDGB318,0001070081,2013.0,Q3,2013-07-01,2013-09-30,2014-11-06 16:25:55+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,23200000.0
PTC Therapeutics Inc,PTCT,549300UJLWOIWFDGB318,0001070081,2013.0,Q3,2013-07-01,2013-09-30,2014-11-06 16:25:55+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.19
PTC Therapeutics Inc,PTCT,549300UJLWOIWFDGB318,0001070081,2013.0,Q3,2013-07-01,2013-09-30,2014-11-06 16:25:55+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,23803282.0
PTC Therapeutics Inc,PTCT,549300UJLWOIWFDGB318,0001070081,2013.0,Q3,2013-07-01,2013-09-30,2014-11-06 16:25:55+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.19
PTC Therapeutics Inc,PTCT,549300UJLWOIWFDGB318,0001070081,2013.0,Q4,2013-10-01,2013-12-31,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,4411000.0
PTC Therapeutics Inc,PTCT,549300UJLWOIWFDGB318,0001070081,2013.0,Q4,2013-10-01,2013-12-31,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,4411000.0
PTC Therapeutics Inc,PTCT,549300UJLWOIWFDGB318,0001070081,2013.0,Q4,2013-10-01,2013-12-31,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,4411000.0
PTC Therapeutics Inc,PTCT,549300UJLWOIWFDGB318,0001070081,2013.0,Q4,2013-10-01,2013-12-31,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,7484000.0
PTC Therapeutics Inc,PTCT,549300UJLWOIWFDGB318,0001070081,2013.0,Q4,2013-10-01,2013-12-31,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,15020000.0
PTC Therapeutics Inc,PTCT,549300UJLWOIWFDGB318,0001070081,2013.0,Q4,2013-10-01,2013-12-31,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,22504000.0
PTC Therapeutics Inc,PTCT,549300UJLWOIWFDGB318,0001070081,2013.0,Q4,2013-10-01,2013-12-31,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-18093000.0
PTC Therapeutics Inc,PTCT,549300UJLWOIWFDGB318,0001070081,2013.0,Q4,2013-10-01,2013-12-31,,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,130000.0
PTC Therapeutics Inc,PTCT,549300UJLWOIWFDGB318,0001070081,2013.0,Q4,2013-10-01,2013-12-31,,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,192000.0
PTC Therapeutics Inc,PTCT,549300UJLWOIWFDGB318,0001070081,2013.0,Q4,2013-10-01,2013-12-31,,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-62000.0
PTC Therapeutics Inc,PTCT,549300UJLWOIWFDGB318,0001070081,2013.0,Q4,2013-10-01,2013-12-31,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-18055000.0
PTC Therapeutics Inc,PTCT,549300UJLWOIWFDGB318,0001070081,2013.0,Q4,2013-10-01,2013-12-31,,netincomecontinuing,othergains,"Other Gains / (Losses), net",+,credit,usd,75000.0
PTC Therapeutics Inc,PTCT,549300UJLWOIWFDGB318,0001070081,2013.0,Q4,2013-10-01,2013-12-31,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-17980000.0
PTC Therapeutics Inc,PTCT,549300UJLWOIWFDGB318,0001070081,2013.0,Q4,2013-10-01,2013-12-31,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-18018000.0
PTC Therapeutics Inc,PTCT,549300UJLWOIWFDGB318,0001070081,2013.0,Q4,2013-10-01,2013-12-31,,netincometocommon,netincometononcontrollinginterest,Net Income / (Loss) Attributable to Noncontrolling Interest,-,debit,usd,-3391000.0
PTC Therapeutics Inc,PTCT,549300UJLWOIWFDGB318,0001070081,2013.0,Q4,2013-10-01,2013-12-31,,netincometocommon,otheradjustmentstonetincometocommon,Other Adjustments to Net Income / (Loss) Attributable to Common Shareholders),-,debit,usd,3261000.0
PTC Therapeutics Inc,PTCT,549300UJLWOIWFDGB318,0001070081,2013.0,Q4,2013-10-01,2013-12-31,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-17888000.0
PTC Therapeutics Inc,PTCT,549300UJLWOIWFDGB318,0001070081,2013.0,Q4,2013-10-01,2013-12-31,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,12800000.0
PTC Therapeutics Inc,PTCT,549300UJLWOIWFDGB318,0001070081,2013.0,Q4,2013-10-01,2013-12-31,,,basiceps,Basic Earnings per Share,=,,usdpershare,6527.82
PTC Therapeutics Inc,PTCT,549300UJLWOIWFDGB318,0001070081,2013.0,Q4,2013-10-01,2013-12-31,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,12800000.0
PTC Therapeutics Inc,PTCT,549300UJLWOIWFDGB318,0001070081,2013.0,Q4,2013-10-01,2013-12-31,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,6527.82
PTC Therapeutics Inc,PTCT,549300UJLWOIWFDGB318,0001070081,2013.0,Q4,2013-10-01,2013-12-31,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,12829411.0
PTC Therapeutics Inc,PTCT,549300UJLWOIWFDGB318,0001070081,2013.0,Q4,2013-10-01,2013-12-31,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,6527.82
PTC Therapeutics Inc,PTCT,549300UJLWOIWFDGB318,0001070081,2014.0,Q1,2014-01-01,2014-03-31,2015-05-05 06:01:00+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,9217000.0
PTC Therapeutics Inc,PTCT,549300UJLWOIWFDGB318,0001070081,2014.0,Q1,2014-01-01,2014-03-31,2015-05-05 06:01:00+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,9217000.0
PTC Therapeutics Inc,PTCT,549300UJLWOIWFDGB318,0001070081,2014.0,Q1,2014-01-01,2014-03-31,2015-05-05 06:01:00+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,9217000.0
PTC Therapeutics Inc,PTCT,549300UJLWOIWFDGB318,0001070081,2014.0,Q1,2014-01-01,2014-03-31,2015-05-05 06:01:00+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,7540000.0
PTC Therapeutics Inc,PTCT,549300UJLWOIWFDGB318,0001070081,2014.0,Q1,2014-01-01,2014-03-31,2015-05-05 06:01:00+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,15889000.0
PTC Therapeutics Inc,PTCT,549300UJLWOIWFDGB318,0001070081,2014.0,Q1,2014-01-01,2014-03-31,2015-05-05 06:01:00+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,23429000.0
PTC Therapeutics Inc,PTCT,549300UJLWOIWFDGB318,0001070081,2014.0,Q1,2014-01-01,2014-03-31,2015-05-05 06:01:00+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-14212000.0
PTC Therapeutics Inc,PTCT,549300UJLWOIWFDGB318,0001070081,2014.0,Q1,2014-01-01,2014-03-31,2015-05-05 06:01:00+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,171000.0
PTC Therapeutics Inc,PTCT,549300UJLWOIWFDGB318,0001070081,2014.0,Q1,2014-01-01,2014-03-31,2015-05-05 06:01:00+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,171000.0
PTC Therapeutics Inc,PTCT,549300UJLWOIWFDGB318,0001070081,2014.0,Q1,2014-01-01,2014-03-31,2015-05-05 06:01:00+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-14041000.0
PTC Therapeutics Inc,PTCT,549300UJLWOIWFDGB318,0001070081,2014.0,Q1,2014-01-01,2014-03-31,2015-05-05 06:01:00+00:00,netincomecontinuing,othergains,"Other Gains / (Losses), net",+,credit,usd,-57000.0
PTC Therapeutics Inc,PTCT,549300UJLWOIWFDGB318,0001070081,2014.0,Q1,2014-01-01,2014-03-31,2015-05-05 06:01:00+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-14098000.0
PTC Therapeutics Inc,PTCT,549300UJLWOIWFDGB318,0001070081,2014.0,Q1,2014-01-01,2014-03-31,2015-05-05 06:01:00+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-14098000.0
PTC Therapeutics Inc,PTCT,549300UJLWOIWFDGB318,0001070081,2014.0,Q1,2014-01-01,2014-03-31,2015-05-05 06:01:00+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-14098000.0
PTC Therapeutics Inc,PTCT,549300UJLWOIWFDGB318,0001070081,2014.0,Q1,2014-01-01,2014-03-31,2015-05-05 06:01:00+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,24300000.0
PTC Therapeutics Inc,PTCT,549300UJLWOIWFDGB318,0001070081,2014.0,Q1,2014-01-01,2014-03-31,2015-05-05 06:01:00+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.58
PTC Therapeutics Inc,PTCT,549300UJLWOIWFDGB318,0001070081,2014.0,Q1,2014-01-01,2014-03-31,2015-05-05 06:01:00+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,24300000.0
PTC Therapeutics Inc,PTCT,549300UJLWOIWFDGB318,0001070081,2014.0,Q1,2014-01-01,2014-03-31,2015-05-05 06:01:00+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.58
PTC Therapeutics Inc,PTCT,549300UJLWOIWFDGB318,0001070081,2014.0,Q1,2014-01-01,2014-03-31,2015-05-05 06:01:00+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,24492487.0
PTC Therapeutics Inc,PTCT,549300UJLWOIWFDGB318,0001070081,2014.0,Q1,2014-01-01,2014-03-31,2015-05-05 06:01:00+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.58
PTC Therapeutics Inc,PTCT,549300UJLWOIWFDGB318,0001070081,2014.0,Q2,2014-04-01,2014-06-30,2015-07-31 06:00:58+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,1677000.0
PTC Therapeutics Inc,PTCT,549300UJLWOIWFDGB318,0001070081,2014.0,Q2,2014-04-01,2014-06-30,2015-07-31 06:00:58+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,1677000.0
PTC Therapeutics Inc,PTCT,549300UJLWOIWFDGB318,0001070081,2014.0,Q2,2014-04-01,2014-06-30,2015-07-31 06:00:58+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,1677000.0
PTC Therapeutics Inc,PTCT,549300UJLWOIWFDGB318,0001070081,2014.0,Q2,2014-04-01,2014-06-30,2015-07-31 06:00:58+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,8733000.0
PTC Therapeutics Inc,PTCT,549300UJLWOIWFDGB318,0001070081,2014.0,Q2,2014-04-01,2014-06-30,2015-07-31 06:00:58+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,18313000.0
PTC Therapeutics Inc,PTCT,549300UJLWOIWFDGB318,0001070081,2014.0,Q2,2014-04-01,2014-06-30,2015-07-31 06:00:58+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,27046000.0
PTC Therapeutics Inc,PTCT,549300UJLWOIWFDGB318,0001070081,2014.0,Q2,2014-04-01,2014-06-30,2015-07-31 06:00:58+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-25369000.0
PTC Therapeutics Inc,PTCT,549300UJLWOIWFDGB318,0001070081,2014.0,Q2,2014-04-01,2014-06-30,2015-07-31 06:00:58+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,248000.0
PTC Therapeutics Inc,PTCT,549300UJLWOIWFDGB318,0001070081,2014.0,Q2,2014-04-01,2014-06-30,2015-07-31 06:00:58+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,17000.0
PTC Therapeutics Inc,PTCT,549300UJLWOIWFDGB318,0001070081,2014.0,Q2,2014-04-01,2014-06-30,2015-07-31 06:00:58+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,265000.0
PTC Therapeutics Inc,PTCT,549300UJLWOIWFDGB318,0001070081,2014.0,Q2,2014-04-01,2014-06-30,2015-07-31 06:00:58+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-25104000.0
PTC Therapeutics Inc,PTCT,549300UJLWOIWFDGB318,0001070081,2014.0,Q2,2014-04-01,2014-06-30,2015-07-31 06:00:58+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-25104000.0
PTC Therapeutics Inc,PTCT,549300UJLWOIWFDGB318,0001070081,2014.0,Q2,2014-04-01,2014-06-30,2015-07-31 06:00:58+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-25104000.0
PTC Therapeutics Inc,PTCT,549300UJLWOIWFDGB318,0001070081,2014.0,Q2,2014-04-01,2014-06-30,2015-07-31 06:00:58+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-25104000.0
PTC Therapeutics Inc,PTCT,549300UJLWOIWFDGB318,0001070081,2014.0,Q2,2014-04-01,2014-06-30,2015-07-31 06:00:58+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,29200000.0
PTC Therapeutics Inc,PTCT,549300UJLWOIWFDGB318,0001070081,2014.0,Q2,2014-04-01,2014-06-30,2015-07-31 06:00:58+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.86
PTC Therapeutics Inc,PTCT,549300UJLWOIWFDGB318,0001070081,2014.0,Q2,2014-04-01,2014-06-30,2015-07-31 06:00:58+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,29200000.0
PTC Therapeutics Inc,PTCT,549300UJLWOIWFDGB318,0001070081,2014.0,Q2,2014-04-01,2014-06-30,2015-07-31 06:00:58+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.86
PTC Therapeutics Inc,PTCT,549300UJLWOIWFDGB318,0001070081,2014.0,Q2,2014-04-01,2014-06-30,2015-07-31 06:00:58+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,29332227.0
PTC Therapeutics Inc,PTCT,549300UJLWOIWFDGB318,0001070081,2014.0,Q2,2014-04-01,2014-06-30,2015-07-31 06:00:58+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.86
PTC Therapeutics Inc,PTCT,549300UJLWOIWFDGB318,0001070081,2014.0,Q3,2014-07-01,2014-09-30,2015-11-09 17:14:26+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,1694000.0
PTC Therapeutics Inc,PTCT,549300UJLWOIWFDGB318,0001070081,2014.0,Q3,2014-07-01,2014-09-30,2015-11-09 17:14:26+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,1694000.0
PTC Therapeutics Inc,PTCT,549300UJLWOIWFDGB318,0001070081,2014.0,Q3,2014-07-01,2014-09-30,2015-11-09 17:14:26+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,1694000.0
PTC Therapeutics Inc,PTCT,549300UJLWOIWFDGB318,0001070081,2014.0,Q3,2014-07-01,2014-09-30,2015-11-09 17:14:26+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,10530000.0
PTC Therapeutics Inc,PTCT,549300UJLWOIWFDGB318,0001070081,2014.0,Q3,2014-07-01,2014-09-30,2015-11-09 17:14:26+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,18765000.0
PTC Therapeutics Inc,PTCT,549300UJLWOIWFDGB318,0001070081,2014.0,Q3,2014-07-01,2014-09-30,2015-11-09 17:14:26+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,29295000.0
PTC Therapeutics Inc,PTCT,549300UJLWOIWFDGB318,0001070081,2014.0,Q3,2014-07-01,2014-09-30,2015-11-09 17:14:26+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-27601000.0
PTC Therapeutics Inc,PTCT,549300UJLWOIWFDGB318,0001070081,2014.0,Q3,2014-07-01,2014-09-30,2015-11-09 17:14:26+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,354000.0
PTC Therapeutics Inc,PTCT,549300UJLWOIWFDGB318,0001070081,2014.0,Q3,2014-07-01,2014-09-30,2015-11-09 17:14:26+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-35000.0
PTC Therapeutics Inc,PTCT,549300UJLWOIWFDGB318,0001070081,2014.0,Q3,2014-07-01,2014-09-30,2015-11-09 17:14:26+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,319000.0
PTC Therapeutics Inc,PTCT,549300UJLWOIWFDGB318,0001070081,2014.0,Q3,2014-07-01,2014-09-30,2015-11-09 17:14:26+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-27282000.0
PTC Therapeutics Inc,PTCT,549300UJLWOIWFDGB318,0001070081,2014.0,Q3,2014-07-01,2014-09-30,2015-11-09 17:14:26+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-27282000.0
PTC Therapeutics Inc,PTCT,549300UJLWOIWFDGB318,0001070081,2014.0,Q3,2014-07-01,2014-09-30,2015-11-09 17:14:26+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-27282000.0
PTC Therapeutics Inc,PTCT,549300UJLWOIWFDGB318,0001070081,2014.0,Q3,2014-07-01,2014-09-30,2015-11-09 17:14:26+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-27282000.0
PTC Therapeutics Inc,PTCT,549300UJLWOIWFDGB318,0001070081,2014.0,Q3,2014-07-01,2014-09-30,2015-11-09 17:14:26+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,29300000.0
PTC Therapeutics Inc,PTCT,549300UJLWOIWFDGB318,0001070081,2014.0,Q3,2014-07-01,2014-09-30,2015-11-09 17:14:26+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.93
PTC Therapeutics Inc,PTCT,549300UJLWOIWFDGB318,0001070081,2014.0,Q3,2014-07-01,2014-09-30,2015-11-09 17:14:26+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,29300000.0
PTC Therapeutics Inc,PTCT,549300UJLWOIWFDGB318,0001070081,2014.0,Q3,2014-07-01,2014-09-30,2015-11-09 17:14:26+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.93
PTC Therapeutics Inc,PTCT,549300UJLWOIWFDGB318,0001070081,2014.0,Q3,2014-07-01,2014-09-30,2015-11-09 17:14:26+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,29351693.0
PTC Therapeutics Inc,PTCT,549300UJLWOIWFDGB318,0001070081,2014.0,Q3,2014-07-01,2014-09-30,2015-11-09 17:14:26+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.93
PTC Therapeutics Inc,PTCT,549300UJLWOIWFDGB318,0001070081,2014.0,Q4,2014-10-01,2014-12-31,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,12657000.0
PTC Therapeutics Inc,PTCT,549300UJLWOIWFDGB318,0001070081,2014.0,Q4,2014-10-01,2014-12-31,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,12657000.0
PTC Therapeutics Inc,PTCT,549300UJLWOIWFDGB318,0001070081,2014.0,Q4,2014-10-01,2014-12-31,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,12657000.0
PTC Therapeutics Inc,PTCT,549300UJLWOIWFDGB318,0001070081,2014.0,Q4,2014-10-01,2014-12-31,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,18017000.0
PTC Therapeutics Inc,PTCT,549300UJLWOIWFDGB318,0001070081,2014.0,Q4,2014-10-01,2014-12-31,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,26871000.0
PTC Therapeutics Inc,PTCT,549300UJLWOIWFDGB318,0001070081,2014.0,Q4,2014-10-01,2014-12-31,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,44888000.0
PTC Therapeutics Inc,PTCT,549300UJLWOIWFDGB318,0001070081,2014.0,Q4,2014-10-01,2014-12-31,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-32231000.0
PTC Therapeutics Inc,PTCT,549300UJLWOIWFDGB318,0001070081,2014.0,Q4,2014-10-01,2014-12-31,,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,407000.0
PTC Therapeutics Inc,PTCT,549300UJLWOIWFDGB318,0001070081,2014.0,Q4,2014-10-01,2014-12-31,,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-195000.0
PTC Therapeutics Inc,PTCT,549300UJLWOIWFDGB318,0001070081,2014.0,Q4,2014-10-01,2014-12-31,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,212000.0
PTC Therapeutics Inc,PTCT,549300UJLWOIWFDGB318,0001070081,2014.0,Q4,2014-10-01,2014-12-31,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-32019000.0
PTC Therapeutics Inc,PTCT,549300UJLWOIWFDGB318,0001070081,2014.0,Q4,2014-10-01,2014-12-31,,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,-4693000.0
PTC Therapeutics Inc,PTCT,549300UJLWOIWFDGB318,0001070081,2014.0,Q4,2014-10-01,2014-12-31,,netincomecontinuing,othergains,"Other Gains / (Losses), net",+,credit,usd,57000.0
PTC Therapeutics Inc,PTCT,549300UJLWOIWFDGB318,0001070081,2014.0,Q4,2014-10-01,2014-12-31,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-27269000.0
PTC Therapeutics Inc,PTCT,549300UJLWOIWFDGB318,0001070081,2014.0,Q4,2014-10-01,2014-12-31,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-27269000.0
PTC Therapeutics Inc,PTCT,549300UJLWOIWFDGB318,0001070081,2014.0,Q4,2014-10-01,2014-12-31,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-27269000.0
PTC Therapeutics Inc,PTCT,549300UJLWOIWFDGB318,0001070081,2014.0,Q4,2014-10-01,2014-12-31,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,31600000.0
PTC Therapeutics Inc,PTCT,549300UJLWOIWFDGB318,0001070081,2014.0,Q4,2014-10-01,2014-12-31,,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.6
PTC Therapeutics Inc,PTCT,549300UJLWOIWFDGB318,0001070081,2014.0,Q4,2014-10-01,2014-12-31,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,31600000.0
PTC Therapeutics Inc,PTCT,549300UJLWOIWFDGB318,0001070081,2014.0,Q4,2014-10-01,2014-12-31,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.6
PTC Therapeutics Inc,PTCT,549300UJLWOIWFDGB318,0001070081,2014.0,Q4,2014-10-01,2014-12-31,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,31565310.0
PTC Therapeutics Inc,PTCT,549300UJLWOIWFDGB318,0001070081,2014.0,Q4,2014-10-01,2014-12-31,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.6
PTC Therapeutics Inc,PTCT,549300UJLWOIWFDGB318,0001070081,2015.0,Q1,2015-01-01,2015-03-31,2016-05-05 16:08:09+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,7482000.0
PTC Therapeutics Inc,PTCT,549300UJLWOIWFDGB318,0001070081,2015.0,Q1,2015-01-01,2015-03-31,2016-05-05 16:08:09+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,7482000.0
PTC Therapeutics Inc,PTCT,549300UJLWOIWFDGB318,0001070081,2015.0,Q1,2015-01-01,2015-03-31,2016-05-05 16:08:09+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,7482000.0
PTC Therapeutics Inc,PTCT,549300UJLWOIWFDGB318,0001070081,2015.0,Q1,2015-01-01,2015-03-31,2016-05-05 16:08:09+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,17615000.0
PTC Therapeutics Inc,PTCT,549300UJLWOIWFDGB318,0001070081,2015.0,Q1,2015-01-01,2015-03-31,2016-05-05 16:08:09+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,27938000.0
PTC Therapeutics Inc,PTCT,549300UJLWOIWFDGB318,0001070081,2015.0,Q1,2015-01-01,2015-03-31,2016-05-05 16:08:09+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,45553000.0
PTC Therapeutics Inc,PTCT,549300UJLWOIWFDGB318,0001070081,2015.0,Q1,2015-01-01,2015-03-31,2016-05-05 16:08:09+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-38071000.0
PTC Therapeutics Inc,PTCT,549300UJLWOIWFDGB318,0001070081,2015.0,Q1,2015-01-01,2015-03-31,2016-05-05 16:08:09+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,524000.0
PTC Therapeutics Inc,PTCT,549300UJLWOIWFDGB318,0001070081,2015.0,Q1,2015-01-01,2015-03-31,2016-05-05 16:08:09+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-368000.0
PTC Therapeutics Inc,PTCT,549300UJLWOIWFDGB318,0001070081,2015.0,Q1,2015-01-01,2015-03-31,2016-05-05 16:08:09+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,156000.0
PTC Therapeutics Inc,PTCT,549300UJLWOIWFDGB318,0001070081,2015.0,Q1,2015-01-01,2015-03-31,2016-05-05 16:08:09+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-37915000.0
PTC Therapeutics Inc,PTCT,549300UJLWOIWFDGB318,0001070081,2015.0,Q1,2015-01-01,2015-03-31,2016-05-05 16:08:09+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-37915000.0
PTC Therapeutics Inc,PTCT,549300UJLWOIWFDGB318,0001070081,2015.0,Q1,2015-01-01,2015-03-31,2016-05-05 16:08:09+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-37915000.0
PTC Therapeutics Inc,PTCT,549300UJLWOIWFDGB318,0001070081,2015.0,Q1,2015-01-01,2015-03-31,2016-05-05 16:08:09+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-37915000.0
PTC Therapeutics Inc,PTCT,549300UJLWOIWFDGB318,0001070081,2015.0,Q1,2015-01-01,2015-03-31,2016-05-05 16:08:09+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,33000000.0
PTC Therapeutics Inc,PTCT,549300UJLWOIWFDGB318,0001070081,2015.0,Q1,2015-01-01,2015-03-31,2016-05-05 16:08:09+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-1.15
PTC Therapeutics Inc,PTCT,549300UJLWOIWFDGB318,0001070081,2015.0,Q1,2015-01-01,2015-03-31,2016-05-05 16:08:09+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,33000000.0
PTC Therapeutics Inc,PTCT,549300UJLWOIWFDGB318,0001070081,2015.0,Q1,2015-01-01,2015-03-31,2016-05-05 16:08:09+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-1.15
PTC Therapeutics Inc,PTCT,549300UJLWOIWFDGB318,0001070081,2015.0,Q1,2015-01-01,2015-03-31,2016-05-05 16:08:09+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,33067752.0
PTC Therapeutics Inc,PTCT,549300UJLWOIWFDGB318,0001070081,2015.0,Q1,2015-01-01,2015-03-31,2016-05-05 16:08:09+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-1.15
PTC Therapeutics Inc,PTCT,549300UJLWOIWFDGB318,0001070081,2015.0,Q2,2015-04-01,2015-06-30,2016-08-04 17:11:54+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,6774000.0
PTC Therapeutics Inc,PTCT,549300UJLWOIWFDGB318,0001070081,2015.0,Q2,2015-04-01,2015-06-30,2016-08-04 17:11:54+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,6774000.0
PTC Therapeutics Inc,PTCT,549300UJLWOIWFDGB318,0001070081,2015.0,Q2,2015-04-01,2015-06-30,2016-08-04 17:11:54+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,6774000.0
PTC Therapeutics Inc,PTCT,549300UJLWOIWFDGB318,0001070081,2015.0,Q2,2015-04-01,2015-06-30,2016-08-04 17:11:54+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,17210000.0
PTC Therapeutics Inc,PTCT,549300UJLWOIWFDGB318,0001070081,2015.0,Q2,2015-04-01,2015-06-30,2016-08-04 17:11:54+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,28190000.0
PTC Therapeutics Inc,PTCT,549300UJLWOIWFDGB318,0001070081,2015.0,Q2,2015-04-01,2015-06-30,2016-08-04 17:11:54+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,45400000.0
PTC Therapeutics Inc,PTCT,549300UJLWOIWFDGB318,0001070081,2015.0,Q2,2015-04-01,2015-06-30,2016-08-04 17:11:54+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-38626000.0
PTC Therapeutics Inc,PTCT,549300UJLWOIWFDGB318,0001070081,2015.0,Q2,2015-04-01,2015-06-30,2016-08-04 17:11:54+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,498000.0
PTC Therapeutics Inc,PTCT,549300UJLWOIWFDGB318,0001070081,2015.0,Q2,2015-04-01,2015-06-30,2016-08-04 17:11:54+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-88000.0
PTC Therapeutics Inc,PTCT,549300UJLWOIWFDGB318,0001070081,2015.0,Q2,2015-04-01,2015-06-30,2016-08-04 17:11:54+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,410000.0
PTC Therapeutics Inc,PTCT,549300UJLWOIWFDGB318,0001070081,2015.0,Q2,2015-04-01,2015-06-30,2016-08-04 17:11:54+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-38216000.0
PTC Therapeutics Inc,PTCT,549300UJLWOIWFDGB318,0001070081,2015.0,Q2,2015-04-01,2015-06-30,2016-08-04 17:11:54+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,145000.0
PTC Therapeutics Inc,PTCT,549300UJLWOIWFDGB318,0001070081,2015.0,Q2,2015-04-01,2015-06-30,2016-08-04 17:11:54+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-38361000.0
PTC Therapeutics Inc,PTCT,549300UJLWOIWFDGB318,0001070081,2015.0,Q2,2015-04-01,2015-06-30,2016-08-04 17:11:54+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-38361000.0
PTC Therapeutics Inc,PTCT,549300UJLWOIWFDGB318,0001070081,2015.0,Q2,2015-04-01,2015-06-30,2016-08-04 17:11:54+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-38361000.0
PTC Therapeutics Inc,PTCT,549300UJLWOIWFDGB318,0001070081,2015.0,Q2,2015-04-01,2015-06-30,2016-08-04 17:11:54+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,33700000.0
PTC Therapeutics Inc,PTCT,549300UJLWOIWFDGB318,0001070081,2015.0,Q2,2015-04-01,2015-06-30,2016-08-04 17:11:54+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-1.14
PTC Therapeutics Inc,PTCT,549300UJLWOIWFDGB318,0001070081,2015.0,Q2,2015-04-01,2015-06-30,2016-08-04 17:11:54+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,33700000.0
PTC Therapeutics Inc,PTCT,549300UJLWOIWFDGB318,0001070081,2015.0,Q2,2015-04-01,2015-06-30,2016-08-04 17:11:54+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-1.14
PTC Therapeutics Inc,PTCT,549300UJLWOIWFDGB318,0001070081,2015.0,Q2,2015-04-01,2015-06-30,2016-08-04 17:11:54+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,33600653.0
PTC Therapeutics Inc,PTCT,549300UJLWOIWFDGB318,0001070081,2015.0,Q2,2015-04-01,2015-06-30,2016-08-04 17:11:54+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-1.14
PTC Therapeutics Inc,PTCT,549300UJLWOIWFDGB318,0001070081,2015.0,Q3,2015-07-01,2015-09-30,2016-11-02 17:45:27+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,9776000.0
PTC Therapeutics Inc,PTCT,549300UJLWOIWFDGB318,0001070081,2015.0,Q3,2015-07-01,2015-09-30,2016-11-02 17:45:27+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,9776000.0
PTC Therapeutics Inc,PTCT,549300UJLWOIWFDGB318,0001070081,2015.0,Q3,2015-07-01,2015-09-30,2016-11-02 17:45:27+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,9776000.0
PTC Therapeutics Inc,PTCT,549300UJLWOIWFDGB318,0001070081,2015.0,Q3,2015-07-01,2015-09-30,2016-11-02 17:45:27+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,21368000.0
PTC Therapeutics Inc,PTCT,549300UJLWOIWFDGB318,0001070081,2015.0,Q3,2015-07-01,2015-09-30,2016-11-02 17:45:27+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,30640000.0
PTC Therapeutics Inc,PTCT,549300UJLWOIWFDGB318,0001070081,2015.0,Q3,2015-07-01,2015-09-30,2016-11-02 17:45:27+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,52008000.0
PTC Therapeutics Inc,PTCT,549300UJLWOIWFDGB318,0001070081,2015.0,Q3,2015-07-01,2015-09-30,2016-11-02 17:45:27+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-42232000.0
PTC Therapeutics Inc,PTCT,549300UJLWOIWFDGB318,0001070081,2015.0,Q3,2015-07-01,2015-09-30,2016-11-02 17:45:27+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,-852000.0
PTC Therapeutics Inc,PTCT,549300UJLWOIWFDGB318,0001070081,2015.0,Q3,2015-07-01,2015-09-30,2016-11-02 17:45:27+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-51000.0
PTC Therapeutics Inc,PTCT,549300UJLWOIWFDGB318,0001070081,2015.0,Q3,2015-07-01,2015-09-30,2016-11-02 17:45:27+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-903000.0
PTC Therapeutics Inc,PTCT,549300UJLWOIWFDGB318,0001070081,2015.0,Q3,2015-07-01,2015-09-30,2016-11-02 17:45:27+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-43135000.0
PTC Therapeutics Inc,PTCT,549300UJLWOIWFDGB318,0001070081,2015.0,Q3,2015-07-01,2015-09-30,2016-11-02 17:45:27+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,88000.0
PTC Therapeutics Inc,PTCT,549300UJLWOIWFDGB318,0001070081,2015.0,Q3,2015-07-01,2015-09-30,2016-11-02 17:45:27+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-43223000.0
PTC Therapeutics Inc,PTCT,549300UJLWOIWFDGB318,0001070081,2015.0,Q3,2015-07-01,2015-09-30,2016-11-02 17:45:27+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-43223000.0
PTC Therapeutics Inc,PTCT,549300UJLWOIWFDGB318,0001070081,2015.0,Q3,2015-07-01,2015-09-30,2016-11-02 17:45:27+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-43223000.0
PTC Therapeutics Inc,PTCT,549300UJLWOIWFDGB318,0001070081,2015.0,Q3,2015-07-01,2015-09-30,2016-11-02 17:45:27+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,34000000.0
PTC Therapeutics Inc,PTCT,549300UJLWOIWFDGB318,0001070081,2015.0,Q3,2015-07-01,2015-09-30,2016-11-02 17:45:27+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-1.27
PTC Therapeutics Inc,PTCT,549300UJLWOIWFDGB318,0001070081,2015.0,Q3,2015-07-01,2015-09-30,2016-11-02 17:45:27+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,34000000.0
PTC Therapeutics Inc,PTCT,549300UJLWOIWFDGB318,0001070081,2015.0,Q3,2015-07-01,2015-09-30,2016-11-02 17:45:27+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-1.27
PTC Therapeutics Inc,PTCT,549300UJLWOIWFDGB318,0001070081,2015.0,Q3,2015-07-01,2015-09-30,2016-11-02 17:45:27+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,33908853.0
PTC Therapeutics Inc,PTCT,549300UJLWOIWFDGB318,0001070081,2015.0,Q3,2015-07-01,2015-09-30,2016-11-02 17:45:27+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-1.27
PTC Therapeutics Inc,PTCT,549300UJLWOIWFDGB318,0001070081,2015.0,Q4,2015-10-01,2015-12-31,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,12734000.0
PTC Therapeutics Inc,PTCT,549300UJLWOIWFDGB318,0001070081,2015.0,Q4,2015-10-01,2015-12-31,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,12734000.0
PTC Therapeutics Inc,PTCT,549300UJLWOIWFDGB318,0001070081,2015.0,Q4,2015-10-01,2015-12-31,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,12734000.0
PTC Therapeutics Inc,PTCT,549300UJLWOIWFDGB318,0001070081,2015.0,Q4,2015-10-01,2015-12-31,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,25887000.0
PTC Therapeutics Inc,PTCT,549300UJLWOIWFDGB318,0001070081,2015.0,Q4,2015-10-01,2015-12-31,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,35048000.0
PTC Therapeutics Inc,PTCT,549300UJLWOIWFDGB318,0001070081,2015.0,Q4,2015-10-01,2015-12-31,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,60935000.0
PTC Therapeutics Inc,PTCT,549300UJLWOIWFDGB318,0001070081,2015.0,Q4,2015-10-01,2015-12-31,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-48201000.0
PTC Therapeutics Inc,PTCT,549300UJLWOIWFDGB318,0001070081,2015.0,Q4,2015-10-01,2015-12-31,,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,-2537000.0
PTC Therapeutics Inc,PTCT,549300UJLWOIWFDGB318,0001070081,2015.0,Q4,2015-10-01,2015-12-31,,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,42000.0
PTC Therapeutics Inc,PTCT,549300UJLWOIWFDGB318,0001070081,2015.0,Q4,2015-10-01,2015-12-31,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-2495000.0
PTC Therapeutics Inc,PTCT,549300UJLWOIWFDGB318,0001070081,2015.0,Q4,2015-10-01,2015-12-31,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-50696000.0
PTC Therapeutics Inc,PTCT,549300UJLWOIWFDGB318,0001070081,2015.0,Q4,2015-10-01,2015-12-31,,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,252000.0
PTC Therapeutics Inc,PTCT,549300UJLWOIWFDGB318,0001070081,2015.0,Q4,2015-10-01,2015-12-31,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-50948000.0
PTC Therapeutics Inc,PTCT,549300UJLWOIWFDGB318,0001070081,2015.0,Q4,2015-10-01,2015-12-31,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-50948000.0
PTC Therapeutics Inc,PTCT,549300UJLWOIWFDGB318,0001070081,2015.0,Q4,2015-10-01,2015-12-31,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-50948000.0
PTC Therapeutics Inc,PTCT,549300UJLWOIWFDGB318,0001070081,2015.0,Q4,2015-10-01,2015-12-31,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,33600000.0
PTC Therapeutics Inc,PTCT,549300UJLWOIWFDGB318,0001070081,2015.0,Q4,2015-10-01,2015-12-31,,,basiceps,Basic Earnings per Share,=,,usdpershare,-1.51
PTC Therapeutics Inc,PTCT,549300UJLWOIWFDGB318,0001070081,2015.0,Q4,2015-10-01,2015-12-31,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,33600000.0
PTC Therapeutics Inc,PTCT,549300UJLWOIWFDGB318,0001070081,2015.0,Q4,2015-10-01,2015-12-31,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-1.51
PTC Therapeutics Inc,PTCT,549300UJLWOIWFDGB318,0001070081,2015.0,Q4,2015-10-01,2015-12-31,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,33626248.0
PTC Therapeutics Inc,PTCT,549300UJLWOIWFDGB318,0001070081,2015.0,Q4,2015-10-01,2015-12-31,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-1.51
PTC Therapeutics Inc,PTCT,549300UJLWOIWFDGB318,0001070081,2016.0,Q1,2016-01-01,2016-03-31,2017-05-08 08:26:42+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,18895000.0
PTC Therapeutics Inc,PTCT,549300UJLWOIWFDGB318,0001070081,2016.0,Q1,2016-01-01,2016-03-31,2017-05-08 08:26:42+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,18895000.0
PTC Therapeutics Inc,PTCT,549300UJLWOIWFDGB318,0001070081,2016.0,Q1,2016-01-01,2016-03-31,2017-05-08 08:26:42+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,0.0
PTC Therapeutics Inc,PTCT,549300UJLWOIWFDGB318,0001070081,2016.0,Q1,2016-01-01,2016-03-31,2017-05-08 08:26:42+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,18895000.0
PTC Therapeutics Inc,PTCT,549300UJLWOIWFDGB318,0001070081,2016.0,Q1,2016-01-01,2016-03-31,2017-05-08 08:26:42+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,25938000.0
PTC Therapeutics Inc,PTCT,549300UJLWOIWFDGB318,0001070081,2016.0,Q1,2016-01-01,2016-03-31,2017-05-08 08:26:42+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,31399000.0
PTC Therapeutics Inc,PTCT,549300UJLWOIWFDGB318,0001070081,2016.0,Q1,2016-01-01,2016-03-31,2017-05-08 08:26:42+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,57337000.0
PTC Therapeutics Inc,PTCT,549300UJLWOIWFDGB318,0001070081,2016.0,Q1,2016-01-01,2016-03-31,2017-05-08 08:26:42+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-38442000.0
PTC Therapeutics Inc,PTCT,549300UJLWOIWFDGB318,0001070081,2016.0,Q1,2016-01-01,2016-03-31,2017-05-08 08:26:42+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,1956000.0
PTC Therapeutics Inc,PTCT,549300UJLWOIWFDGB318,0001070081,2016.0,Q1,2016-01-01,2016-03-31,2017-05-08 08:26:42+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-721000.0
PTC Therapeutics Inc,PTCT,549300UJLWOIWFDGB318,0001070081,2016.0,Q1,2016-01-01,2016-03-31,2017-05-08 08:26:42+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-2677000.0
PTC Therapeutics Inc,PTCT,549300UJLWOIWFDGB318,0001070081,2016.0,Q1,2016-01-01,2016-03-31,2017-05-08 08:26:42+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-41119000.0
PTC Therapeutics Inc,PTCT,549300UJLWOIWFDGB318,0001070081,2016.0,Q1,2016-01-01,2016-03-31,2017-05-08 08:26:42+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,114000.0
PTC Therapeutics Inc,PTCT,549300UJLWOIWFDGB318,0001070081,2016.0,Q1,2016-01-01,2016-03-31,2017-05-08 08:26:42+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-41233000.0
PTC Therapeutics Inc,PTCT,549300UJLWOIWFDGB318,0001070081,2016.0,Q1,2016-01-01,2016-03-31,2017-05-08 08:26:42+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-41233000.0
PTC Therapeutics Inc,PTCT,549300UJLWOIWFDGB318,0001070081,2016.0,Q1,2016-01-01,2016-03-31,2017-05-08 08:26:42+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-41233000.0
PTC Therapeutics Inc,PTCT,549300UJLWOIWFDGB318,0001070081,2016.0,Q1,2016-01-01,2016-03-31,2017-05-08 08:26:42+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,33800000.0
PTC Therapeutics Inc,PTCT,549300UJLWOIWFDGB318,0001070081,2016.0,Q1,2016-01-01,2016-03-31,2017-05-08 08:26:42+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-1.22
PTC Therapeutics Inc,PTCT,549300UJLWOIWFDGB318,0001070081,2016.0,Q1,2016-01-01,2016-03-31,2017-05-08 08:26:42+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,33800000.0
PTC Therapeutics Inc,PTCT,549300UJLWOIWFDGB318,0001070081,2016.0,Q1,2016-01-01,2016-03-31,2017-05-08 08:26:42+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-1.22
PTC Therapeutics Inc,PTCT,549300UJLWOIWFDGB318,0001070081,2016.0,Q1,2016-01-01,2016-03-31,2017-05-08 08:26:42+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,33919169.0
PTC Therapeutics Inc,PTCT,549300UJLWOIWFDGB318,0001070081,2016.0,Q1,2016-01-01,2016-03-31,2017-05-08 08:26:42+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-1.22
PTC Therapeutics Inc,PTCT,549300UJLWOIWFDGB318,0001070081,2016.0,Q2,2016-04-01,2016-06-30,2017-08-09 08:33:48+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,15633000.0
PTC Therapeutics Inc,PTCT,549300UJLWOIWFDGB318,0001070081,2016.0,Q2,2016-04-01,2016-06-30,2017-08-09 08:33:48+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,15633000.0
PTC Therapeutics Inc,PTCT,549300UJLWOIWFDGB318,0001070081,2016.0,Q2,2016-04-01,2016-06-30,2017-08-09 08:33:48+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,15633000.0
PTC Therapeutics Inc,PTCT,549300UJLWOIWFDGB318,0001070081,2016.0,Q2,2016-04-01,2016-06-30,2017-08-09 08:33:48+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,23366000.0
PTC Therapeutics Inc,PTCT,549300UJLWOIWFDGB318,0001070081,2016.0,Q2,2016-04-01,2016-06-30,2017-08-09 08:33:48+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,28827000.0
PTC Therapeutics Inc,PTCT,549300UJLWOIWFDGB318,0001070081,2016.0,Q2,2016-04-01,2016-06-30,2017-08-09 08:33:48+00:00,totaloperatingexpenses,otheroperatingexpenses,Other Operating Expenses / (Income),+,debit,usd,0.0
PTC Therapeutics Inc,PTCT,549300UJLWOIWFDGB318,0001070081,2016.0,Q2,2016-04-01,2016-06-30,2017-08-09 08:33:48+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,52193000.0
PTC Therapeutics Inc,PTCT,549300UJLWOIWFDGB318,0001070081,2016.0,Q2,2016-04-01,2016-06-30,2017-08-09 08:33:48+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-36560000.0
PTC Therapeutics Inc,PTCT,549300UJLWOIWFDGB318,0001070081,2016.0,Q2,2016-04-01,2016-06-30,2017-08-09 08:33:48+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,2060000.0
PTC Therapeutics Inc,PTCT,549300UJLWOIWFDGB318,0001070081,2016.0,Q2,2016-04-01,2016-06-30,2017-08-09 08:33:48+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-387000.0
PTC Therapeutics Inc,PTCT,549300UJLWOIWFDGB318,0001070081,2016.0,Q2,2016-04-01,2016-06-30,2017-08-09 08:33:48+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-2447000.0
PTC Therapeutics Inc,PTCT,549300UJLWOIWFDGB318,0001070081,2016.0,Q2,2016-04-01,2016-06-30,2017-08-09 08:33:48+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-39007000.0
PTC Therapeutics Inc,PTCT,549300UJLWOIWFDGB318,0001070081,2016.0,Q2,2016-04-01,2016-06-30,2017-08-09 08:33:48+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,-93000.0
PTC Therapeutics Inc,PTCT,549300UJLWOIWFDGB318,0001070081,2016.0,Q2,2016-04-01,2016-06-30,2017-08-09 08:33:48+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-38914000.0
PTC Therapeutics Inc,PTCT,549300UJLWOIWFDGB318,0001070081,2016.0,Q2,2016-04-01,2016-06-30,2017-08-09 08:33:48+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-38914000.0
PTC Therapeutics Inc,PTCT,549300UJLWOIWFDGB318,0001070081,2016.0,Q2,2016-04-01,2016-06-30,2017-08-09 08:33:48+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-38914000.0
PTC Therapeutics Inc,PTCT,549300UJLWOIWFDGB318,0001070081,2016.0,Q2,2016-04-01,2016-06-30,2017-08-09 08:33:48+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,34100000.0
PTC Therapeutics Inc,PTCT,549300UJLWOIWFDGB318,0001070081,2016.0,Q2,2016-04-01,2016-06-30,2017-08-09 08:33:48+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-1.14
PTC Therapeutics Inc,PTCT,549300UJLWOIWFDGB318,0001070081,2016.0,Q2,2016-04-01,2016-06-30,2017-08-09 08:33:48+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,34100000.0
PTC Therapeutics Inc,PTCT,549300UJLWOIWFDGB318,0001070081,2016.0,Q2,2016-04-01,2016-06-30,2017-08-09 08:33:48+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-1.14
PTC Therapeutics Inc,PTCT,549300UJLWOIWFDGB318,0001070081,2016.0,Q2,2016-04-01,2016-06-30,2017-08-09 08:33:48+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,34000333.0
PTC Therapeutics Inc,PTCT,549300UJLWOIWFDGB318,0001070081,2016.0,Q2,2016-04-01,2016-06-30,2017-08-09 08:33:48+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-1.14
PTC Therapeutics Inc,PTCT,549300UJLWOIWFDGB318,0001070081,2016.0,Q3,2016-07-01,2016-09-30,2017-11-02 16:39:03+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,22986000.0
PTC Therapeutics Inc,PTCT,549300UJLWOIWFDGB318,0001070081,2016.0,Q3,2016-07-01,2016-09-30,2017-11-02 16:39:03+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,22986000.0
PTC Therapeutics Inc,PTCT,549300UJLWOIWFDGB318,0001070081,2016.0,Q3,2016-07-01,2016-09-30,2017-11-02 16:39:03+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,0.0
PTC Therapeutics Inc,PTCT,549300UJLWOIWFDGB318,0001070081,2016.0,Q3,2016-07-01,2016-09-30,2017-11-02 16:39:03+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,22986000.0
PTC Therapeutics Inc,PTCT,549300UJLWOIWFDGB318,0001070081,2016.0,Q3,2016-07-01,2016-09-30,2017-11-02 16:39:03+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,23654000.0
PTC Therapeutics Inc,PTCT,549300UJLWOIWFDGB318,0001070081,2016.0,Q3,2016-07-01,2016-09-30,2017-11-02 16:39:03+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,31396000.0
PTC Therapeutics Inc,PTCT,549300UJLWOIWFDGB318,0001070081,2016.0,Q3,2016-07-01,2016-09-30,2017-11-02 16:39:03+00:00,totaloperatingexpenses,amortizationexpense,Amortization Expense,+,debit,usd,0.0
PTC Therapeutics Inc,PTCT,549300UJLWOIWFDGB318,0001070081,2016.0,Q3,2016-07-01,2016-09-30,2017-11-02 16:39:03+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,55050000.0
PTC Therapeutics Inc,PTCT,549300UJLWOIWFDGB318,0001070081,2016.0,Q3,2016-07-01,2016-09-30,2017-11-02 16:39:03+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-32064000.0
PTC Therapeutics Inc,PTCT,549300UJLWOIWFDGB318,0001070081,2016.0,Q3,2016-07-01,2016-09-30,2017-11-02 16:39:03+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,-2133000.0
PTC Therapeutics Inc,PTCT,549300UJLWOIWFDGB318,0001070081,2016.0,Q3,2016-07-01,2016-09-30,2017-11-02 16:39:03+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-786000.0
PTC Therapeutics Inc,PTCT,549300UJLWOIWFDGB318,0001070081,2016.0,Q3,2016-07-01,2016-09-30,2017-11-02 16:39:03+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-2919000.0
PTC Therapeutics Inc,PTCT,549300UJLWOIWFDGB318,0001070081,2016.0,Q3,2016-07-01,2016-09-30,2017-11-02 16:39:03+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-34983000.0
PTC Therapeutics Inc,PTCT,549300UJLWOIWFDGB318,0001070081,2016.0,Q3,2016-07-01,2016-09-30,2017-11-02 16:39:03+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,184000.0
PTC Therapeutics Inc,PTCT,549300UJLWOIWFDGB318,0001070081,2016.0,Q3,2016-07-01,2016-09-30,2017-11-02 16:39:03+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-35167000.0
PTC Therapeutics Inc,PTCT,549300UJLWOIWFDGB318,0001070081,2016.0,Q3,2016-07-01,2016-09-30,2017-11-02 16:39:03+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-35167000.0
PTC Therapeutics Inc,PTCT,549300UJLWOIWFDGB318,0001070081,2016.0,Q3,2016-07-01,2016-09-30,2017-11-02 16:39:03+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-35167000.0
PTC Therapeutics Inc,PTCT,549300UJLWOIWFDGB318,0001070081,2016.0,Q3,2016-07-01,2016-09-30,2017-11-02 16:39:03+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,34100000.0
PTC Therapeutics Inc,PTCT,549300UJLWOIWFDGB318,0001070081,2016.0,Q3,2016-07-01,2016-09-30,2017-11-02 16:39:03+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-1.03
PTC Therapeutics Inc,PTCT,549300UJLWOIWFDGB318,0001070081,2016.0,Q3,2016-07-01,2016-09-30,2017-11-02 16:39:03+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,34100000.0
PTC Therapeutics Inc,PTCT,549300UJLWOIWFDGB318,0001070081,2016.0,Q3,2016-07-01,2016-09-30,2017-11-02 16:39:03+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-1.03
PTC Therapeutics Inc,PTCT,549300UJLWOIWFDGB318,0001070081,2016.0,Q3,2016-07-01,2016-09-30,2017-11-02 16:39:03+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,34088741.0
PTC Therapeutics Inc,PTCT,549300UJLWOIWFDGB318,0001070081,2016.0,Q3,2016-07-01,2016-09-30,2017-11-02 16:39:03+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-1.03
PTC Therapeutics Inc,PTCT,549300UJLWOIWFDGB318,0001070081,2016.0,Q4,2016-10-01,2016-12-31,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,25191000.0
PTC Therapeutics Inc,PTCT,549300UJLWOIWFDGB318,0001070081,2016.0,Q4,2016-10-01,2016-12-31,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,25191000.0
PTC Therapeutics Inc,PTCT,549300UJLWOIWFDGB318,0001070081,2016.0,Q4,2016-10-01,2016-12-31,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,25191000.0
PTC Therapeutics Inc,PTCT,549300UJLWOIWFDGB318,0001070081,2016.0,Q4,2016-10-01,2016-12-31,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,24172000.0
PTC Therapeutics Inc,PTCT,549300UJLWOIWFDGB318,0001070081,2016.0,Q4,2016-10-01,2016-12-31,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,26011000.0
PTC Therapeutics Inc,PTCT,549300UJLWOIWFDGB318,0001070081,2016.0,Q4,2016-10-01,2016-12-31,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,50183000.0
PTC Therapeutics Inc,PTCT,549300UJLWOIWFDGB318,0001070081,2016.0,Q4,2016-10-01,2016-12-31,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-24992000.0
PTC Therapeutics Inc,PTCT,549300UJLWOIWFDGB318,0001070081,2016.0,Q4,2016-10-01,2016-12-31,,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,-4016000.0
PTC Therapeutics Inc,PTCT,549300UJLWOIWFDGB318,0001070081,2016.0,Q4,2016-10-01,2016-12-31,,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,-6143000.0
PTC Therapeutics Inc,PTCT,549300UJLWOIWFDGB318,0001070081,2016.0,Q4,2016-10-01,2016-12-31,,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,687000.0
PTC Therapeutics Inc,PTCT,549300UJLWOIWFDGB318,0001070081,2016.0,Q4,2016-10-01,2016-12-31,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-1440000.0
PTC Therapeutics Inc,PTCT,549300UJLWOIWFDGB318,0001070081,2016.0,Q4,2016-10-01,2016-12-31,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-26432000.0
PTC Therapeutics Inc,PTCT,549300UJLWOIWFDGB318,0001070081,2016.0,Q4,2016-10-01,2016-12-31,,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,364000.0
PTC Therapeutics Inc,PTCT,549300UJLWOIWFDGB318,0001070081,2016.0,Q4,2016-10-01,2016-12-31,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-26796000.0
PTC Therapeutics Inc,PTCT,549300UJLWOIWFDGB318,0001070081,2016.0,Q4,2016-10-01,2016-12-31,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-26796000.0
PTC Therapeutics Inc,PTCT,549300UJLWOIWFDGB318,0001070081,2016.0,Q4,2016-10-01,2016-12-31,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-26796000.0
PTC Therapeutics Inc,PTCT,549300UJLWOIWFDGB318,0001070081,2016.0,Q4,2016-10-01,2016-12-31,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,34100000.0
PTC Therapeutics Inc,PTCT,549300UJLWOIWFDGB318,0001070081,2016.0,Q4,2016-10-01,2016-12-31,,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.78
PTC Therapeutics Inc,PTCT,549300UJLWOIWFDGB318,0001070081,2016.0,Q4,2016-10-01,2016-12-31,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,34100000.0
PTC Therapeutics Inc,PTCT,549300UJLWOIWFDGB318,0001070081,2016.0,Q4,2016-10-01,2016-12-31,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.78
PTC Therapeutics Inc,PTCT,549300UJLWOIWFDGB318,0001070081,2016.0,Q4,2016-10-01,2016-12-31,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,34044584.0
PTC Therapeutics Inc,PTCT,549300UJLWOIWFDGB318,0001070081,2016.0,Q4,2016-10-01,2016-12-31,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.78
PTC Therapeutics Inc,PTCT,549300UJLWOIWFDGB318,0001070081,2017.0,Q1,2017-01-01,2017-03-31,2018-05-09 16:48:31+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,26547000.0
PTC Therapeutics Inc,PTCT,549300UJLWOIWFDGB318,0001070081,2017.0,Q1,2017-01-01,2017-03-31,2018-05-09 16:48:31+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,26547000.0
PTC Therapeutics Inc,PTCT,549300UJLWOIWFDGB318,0001070081,2017.0,Q1,2017-01-01,2017-03-31,2018-05-09 16:48:31+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,39000.0
PTC Therapeutics Inc,PTCT,549300UJLWOIWFDGB318,0001070081,2017.0,Q1,2017-01-01,2017-03-31,2018-05-09 16:48:31+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,39000.0
PTC Therapeutics Inc,PTCT,549300UJLWOIWFDGB318,0001070081,2017.0,Q1,2017-01-01,2017-03-31,2018-05-09 16:48:31+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,26508000.0
PTC Therapeutics Inc,PTCT,549300UJLWOIWFDGB318,0001070081,2017.0,Q1,2017-01-01,2017-03-31,2018-05-09 16:48:31+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,25500000.0
PTC Therapeutics Inc,PTCT,549300UJLWOIWFDGB318,0001070081,2017.0,Q1,2017-01-01,2017-03-31,2018-05-09 16:48:31+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,27363000.0
PTC Therapeutics Inc,PTCT,549300UJLWOIWFDGB318,0001070081,2017.0,Q1,2017-01-01,2017-03-31,2018-05-09 16:48:31+00:00,totaloperatingexpenses,amortizationexpense,Amortization Expense,+,debit,usd,0.0
PTC Therapeutics Inc,PTCT,549300UJLWOIWFDGB318,0001070081,2017.0,Q1,2017-01-01,2017-03-31,2018-05-09 16:48:31+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,52863000.0
PTC Therapeutics Inc,PTCT,549300UJLWOIWFDGB318,0001070081,2017.0,Q1,2017-01-01,2017-03-31,2018-05-09 16:48:31+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-26355000.0
PTC Therapeutics Inc,PTCT,549300UJLWOIWFDGB318,0001070081,2017.0,Q1,2017-01-01,2017-03-31,2018-05-09 16:48:31+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,-2219000.0
PTC Therapeutics Inc,PTCT,549300UJLWOIWFDGB318,0001070081,2017.0,Q1,2017-01-01,2017-03-31,2018-05-09 16:48:31+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-318000.0
PTC Therapeutics Inc,PTCT,549300UJLWOIWFDGB318,0001070081,2017.0,Q1,2017-01-01,2017-03-31,2018-05-09 16:48:31+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-2537000.0
PTC Therapeutics Inc,PTCT,549300UJLWOIWFDGB318,0001070081,2017.0,Q1,2017-01-01,2017-03-31,2018-05-09 16:48:31+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-28892000.0
PTC Therapeutics Inc,PTCT,549300UJLWOIWFDGB318,0001070081,2017.0,Q1,2017-01-01,2017-03-31,2018-05-09 16:48:31+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,165000.0
PTC Therapeutics Inc,PTCT,549300UJLWOIWFDGB318,0001070081,2017.0,Q1,2017-01-01,2017-03-31,2018-05-09 16:48:31+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-29057000.0
PTC Therapeutics Inc,PTCT,549300UJLWOIWFDGB318,0001070081,2017.0,Q1,2017-01-01,2017-03-31,2018-05-09 16:48:31+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-29057000.0
PTC Therapeutics Inc,PTCT,549300UJLWOIWFDGB318,0001070081,2017.0,Q1,2017-01-01,2017-03-31,2018-05-09 16:48:31+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-29057000.0
PTC Therapeutics Inc,PTCT,549300UJLWOIWFDGB318,0001070081,2017.0,Q1,2017-01-01,2017-03-31,2018-05-09 16:48:31+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,34200000.0
PTC Therapeutics Inc,PTCT,549300UJLWOIWFDGB318,0001070081,2017.0,Q1,2017-01-01,2017-03-31,2018-05-09 16:48:31+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.85
PTC Therapeutics Inc,PTCT,549300UJLWOIWFDGB318,0001070081,2017.0,Q1,2017-01-01,2017-03-31,2018-05-09 16:48:31+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,34200000.0
PTC Therapeutics Inc,PTCT,549300UJLWOIWFDGB318,0001070081,2017.0,Q1,2017-01-01,2017-03-31,2018-05-09 16:48:31+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.85
PTC Therapeutics Inc,PTCT,549300UJLWOIWFDGB318,0001070081,2017.0,Q1,2017-01-01,2017-03-31,2018-05-09 16:48:31+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,34305948.0
PTC Therapeutics Inc,PTCT,549300UJLWOIWFDGB318,0001070081,2017.0,Q1,2017-01-01,2017-03-31,2018-05-09 16:48:31+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.85
PTC Therapeutics Inc,PTCT,549300UJLWOIWFDGB318,0001070081,2017.0,Q2,2017-04-01,2017-06-30,2018-08-07 16:46:15+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,47962000.0
PTC Therapeutics Inc,PTCT,549300UJLWOIWFDGB318,0001070081,2017.0,Q2,2017-04-01,2017-06-30,2018-08-07 16:46:15+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,47962000.0
PTC Therapeutics Inc,PTCT,549300UJLWOIWFDGB318,0001070081,2017.0,Q2,2017-04-01,2017-06-30,2018-08-07 16:46:15+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,758000.0
PTC Therapeutics Inc,PTCT,549300UJLWOIWFDGB318,0001070081,2017.0,Q2,2017-04-01,2017-06-30,2018-08-07 16:46:15+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,758000.0
PTC Therapeutics Inc,PTCT,549300UJLWOIWFDGB318,0001070081,2017.0,Q2,2017-04-01,2017-06-30,2018-08-07 16:46:15+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,47204000.0
PTC Therapeutics Inc,PTCT,549300UJLWOIWFDGB318,0001070081,2017.0,Q2,2017-04-01,2017-06-30,2018-08-07 16:46:15+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,28866000.0
PTC Therapeutics Inc,PTCT,549300UJLWOIWFDGB318,0001070081,2017.0,Q2,2017-04-01,2017-06-30,2018-08-07 16:46:15+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,30835000.0
PTC Therapeutics Inc,PTCT,549300UJLWOIWFDGB318,0001070081,2017.0,Q2,2017-04-01,2017-06-30,2018-08-07 16:46:15+00:00,totaloperatingexpenses,amortizationexpense,Amortization Expense,+,debit,usd,0.0
PTC Therapeutics Inc,PTCT,549300UJLWOIWFDGB318,0001070081,2017.0,Q2,2017-04-01,2017-06-30,2018-08-07 16:46:15+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,59701000.0
PTC Therapeutics Inc,PTCT,549300UJLWOIWFDGB318,0001070081,2017.0,Q2,2017-04-01,2017-06-30,2018-08-07 16:46:15+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-12497000.0
PTC Therapeutics Inc,PTCT,549300UJLWOIWFDGB318,0001070081,2017.0,Q2,2017-04-01,2017-06-30,2018-08-07 16:46:15+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,-3008000.0
PTC Therapeutics Inc,PTCT,549300UJLWOIWFDGB318,0001070081,2017.0,Q2,2017-04-01,2017-06-30,2018-08-07 16:46:15+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-1820000.0
PTC Therapeutics Inc,PTCT,549300UJLWOIWFDGB318,0001070081,2017.0,Q2,2017-04-01,2017-06-30,2018-08-07 16:46:15+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-4828000.0
PTC Therapeutics Inc,PTCT,549300UJLWOIWFDGB318,0001070081,2017.0,Q2,2017-04-01,2017-06-30,2018-08-07 16:46:15+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-17325000.0
PTC Therapeutics Inc,PTCT,549300UJLWOIWFDGB318,0001070081,2017.0,Q2,2017-04-01,2017-06-30,2018-08-07 16:46:15+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,150000.0
PTC Therapeutics Inc,PTCT,549300UJLWOIWFDGB318,0001070081,2017.0,Q2,2017-04-01,2017-06-30,2018-08-07 16:46:15+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-17475000.0
PTC Therapeutics Inc,PTCT,549300UJLWOIWFDGB318,0001070081,2017.0,Q2,2017-04-01,2017-06-30,2018-08-07 16:46:15+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-17475000.0
PTC Therapeutics Inc,PTCT,549300UJLWOIWFDGB318,0001070081,2017.0,Q2,2017-04-01,2017-06-30,2018-08-07 16:46:15+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-17475000.0
PTC Therapeutics Inc,PTCT,549300UJLWOIWFDGB318,0001070081,2017.0,Q2,2017-04-01,2017-06-30,2018-08-07 16:46:15+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,39700000.0
PTC Therapeutics Inc,PTCT,549300UJLWOIWFDGB318,0001070081,2017.0,Q2,2017-04-01,2017-06-30,2018-08-07 16:46:15+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.44
PTC Therapeutics Inc,PTCT,549300UJLWOIWFDGB318,0001070081,2017.0,Q2,2017-04-01,2017-06-30,2018-08-07 16:46:15+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,39700000.0
PTC Therapeutics Inc,PTCT,549300UJLWOIWFDGB318,0001070081,2017.0,Q2,2017-04-01,2017-06-30,2018-08-07 16:46:15+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.44
PTC Therapeutics Inc,PTCT,549300UJLWOIWFDGB318,0001070081,2017.0,Q2,2017-04-01,2017-06-30,2018-08-07 16:46:15+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,39621738.0
PTC Therapeutics Inc,PTCT,549300UJLWOIWFDGB318,0001070081,2017.0,Q2,2017-04-01,2017-06-30,2018-08-07 16:46:15+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.44
PTC Therapeutics Inc,PTCT,549300UJLWOIWFDGB318,0001070081,2017.0,Q3,2017-07-01,2017-09-30,2018-11-05 17:16:48+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,41853000.0
PTC Therapeutics Inc,PTCT,549300UJLWOIWFDGB318,0001070081,2017.0,Q3,2017-07-01,2017-09-30,2018-11-05 17:16:48+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,41853000.0
PTC Therapeutics Inc,PTCT,549300UJLWOIWFDGB318,0001070081,2017.0,Q3,2017-07-01,2017-09-30,2018-11-05 17:16:48+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,1582000.0
PTC Therapeutics Inc,PTCT,549300UJLWOIWFDGB318,0001070081,2017.0,Q3,2017-07-01,2017-09-30,2018-11-05 17:16:48+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,1582000.0
PTC Therapeutics Inc,PTCT,549300UJLWOIWFDGB318,0001070081,2017.0,Q3,2017-07-01,2017-09-30,2018-11-05 17:16:48+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,40271000.0
PTC Therapeutics Inc,PTCT,549300UJLWOIWFDGB318,0001070081,2017.0,Q3,2017-07-01,2017-09-30,2018-11-05 17:16:48+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,31423000.0
PTC Therapeutics Inc,PTCT,549300UJLWOIWFDGB318,0001070081,2017.0,Q3,2017-07-01,2017-09-30,2018-11-05 17:16:48+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,30024000.0
PTC Therapeutics Inc,PTCT,549300UJLWOIWFDGB318,0001070081,2017.0,Q3,2017-07-01,2017-09-30,2018-11-05 17:16:48+00:00,totaloperatingexpenses,amortizationexpense,Amortization Expense,+,debit,usd,9716000.0
PTC Therapeutics Inc,PTCT,549300UJLWOIWFDGB318,0001070081,2017.0,Q3,2017-07-01,2017-09-30,2018-11-05 17:16:48+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,71163000.0
PTC Therapeutics Inc,PTCT,549300UJLWOIWFDGB318,0001070081,2017.0,Q3,2017-07-01,2017-09-30,2018-11-05 17:16:48+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-30892000.0
PTC Therapeutics Inc,PTCT,549300UJLWOIWFDGB318,0001070081,2017.0,Q3,2017-07-01,2017-09-30,2018-11-05 17:16:48+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,-3421000.0
PTC Therapeutics Inc,PTCT,549300UJLWOIWFDGB318,0001070081,2017.0,Q3,2017-07-01,2017-09-30,2018-11-05 17:16:48+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,766000.0
PTC Therapeutics Inc,PTCT,549300UJLWOIWFDGB318,0001070081,2017.0,Q3,2017-07-01,2017-09-30,2018-11-05 17:16:48+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-2655000.0
PTC Therapeutics Inc,PTCT,549300UJLWOIWFDGB318,0001070081,2017.0,Q3,2017-07-01,2017-09-30,2018-11-05 17:16:48+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-33547000.0
PTC Therapeutics Inc,PTCT,549300UJLWOIWFDGB318,0001070081,2017.0,Q3,2017-07-01,2017-09-30,2018-11-05 17:16:48+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,191000.0
PTC Therapeutics Inc,PTCT,549300UJLWOIWFDGB318,0001070081,2017.0,Q3,2017-07-01,2017-09-30,2018-11-05 17:16:48+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-33738000.0
PTC Therapeutics Inc,PTCT,549300UJLWOIWFDGB318,0001070081,2017.0,Q3,2017-07-01,2017-09-30,2018-11-05 17:16:48+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-33738000.0
PTC Therapeutics Inc,PTCT,549300UJLWOIWFDGB318,0001070081,2017.0,Q3,2017-07-01,2017-09-30,2018-11-05 17:16:48+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-33738000.0
PTC Therapeutics Inc,PTCT,549300UJLWOIWFDGB318,0001070081,2017.0,Q3,2017-07-01,2017-09-30,2018-11-05 17:16:48+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,41100000.0
PTC Therapeutics Inc,PTCT,549300UJLWOIWFDGB318,0001070081,2017.0,Q3,2017-07-01,2017-09-30,2018-11-05 17:16:48+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.82
PTC Therapeutics Inc,PTCT,549300UJLWOIWFDGB318,0001070081,2017.0,Q3,2017-07-01,2017-09-30,2018-11-05 17:16:48+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,41100000.0
PTC Therapeutics Inc,PTCT,549300UJLWOIWFDGB318,0001070081,2017.0,Q3,2017-07-01,2017-09-30,2018-11-05 17:16:48+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.82
PTC Therapeutics Inc,PTCT,549300UJLWOIWFDGB318,0001070081,2017.0,Q3,2017-07-01,2017-09-30,2018-11-05 17:16:48+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,41296740.0
PTC Therapeutics Inc,PTCT,549300UJLWOIWFDGB318,0001070081,2017.0,Q3,2017-07-01,2017-09-30,2018-11-05 17:16:48+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.82
PTC Therapeutics Inc,PTCT,549300UJLWOIWFDGB318,0001070081,2017.0,Q4,2017-10-01,2017-12-31,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,78030000.0
PTC Therapeutics Inc,PTCT,549300UJLWOIWFDGB318,0001070081,2017.0,Q4,2017-10-01,2017-12-31,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,78030000.0
PTC Therapeutics Inc,PTCT,549300UJLWOIWFDGB318,0001070081,2017.0,Q4,2017-10-01,2017-12-31,,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,2198000.0
PTC Therapeutics Inc,PTCT,549300UJLWOIWFDGB318,0001070081,2017.0,Q4,2017-10-01,2017-12-31,,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,2198000.0
PTC Therapeutics Inc,PTCT,549300UJLWOIWFDGB318,0001070081,2017.0,Q4,2017-10-01,2017-12-31,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,75832000.0
PTC Therapeutics Inc,PTCT,549300UJLWOIWFDGB318,0001070081,2017.0,Q4,2017-10-01,2017-12-31,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,35482000.0
PTC Therapeutics Inc,PTCT,549300UJLWOIWFDGB318,0001070081,2017.0,Q4,2017-10-01,2017-12-31,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,29234000.0
PTC Therapeutics Inc,PTCT,549300UJLWOIWFDGB318,0001070081,2017.0,Q4,2017-10-01,2017-12-31,,totaloperatingexpenses,amortizationexpense,Amortization Expense,+,debit,usd,5664000.0
PTC Therapeutics Inc,PTCT,549300UJLWOIWFDGB318,0001070081,2017.0,Q4,2017-10-01,2017-12-31,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,70380000.0
PTC Therapeutics Inc,PTCT,549300UJLWOIWFDGB318,0001070081,2017.0,Q4,2017-10-01,2017-12-31,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,5452000.0
PTC Therapeutics Inc,PTCT,549300UJLWOIWFDGB318,0001070081,2017.0,Q4,2017-10-01,2017-12-31,,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,-3446000.0
PTC Therapeutics Inc,PTCT,549300UJLWOIWFDGB318,0001070081,2017.0,Q4,2017-10-01,2017-12-31,,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,93000.0
PTC Therapeutics Inc,PTCT,549300UJLWOIWFDGB318,0001070081,2017.0,Q4,2017-10-01,2017-12-31,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-3353000.0
PTC Therapeutics Inc,PTCT,549300UJLWOIWFDGB318,0001070081,2017.0,Q4,2017-10-01,2017-12-31,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,2099000.0
PTC Therapeutics Inc,PTCT,549300UJLWOIWFDGB318,0001070081,2017.0,Q4,2017-10-01,2017-12-31,,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,829000.0
PTC Therapeutics Inc,PTCT,549300UJLWOIWFDGB318,0001070081,2017.0,Q4,2017-10-01,2017-12-31,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,1270000.0
PTC Therapeutics Inc,PTCT,549300UJLWOIWFDGB318,0001070081,2017.0,Q4,2017-10-01,2017-12-31,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,1270000.0
PTC Therapeutics Inc,PTCT,549300UJLWOIWFDGB318,0001070081,2017.0,Q4,2017-10-01,2017-12-31,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,1270000.0
PTC Therapeutics Inc,PTCT,549300UJLWOIWFDGB318,0001070081,2017.0,Q4,2017-10-01,2017-12-31,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,39100000.0
PTC Therapeutics Inc,PTCT,549300UJLWOIWFDGB318,0001070081,2017.0,Q4,2017-10-01,2017-12-31,,,basiceps,Basic Earnings per Share,=,,usdpershare,0.09
PTC Therapeutics Inc,PTCT,549300UJLWOIWFDGB318,0001070081,2017.0,Q4,2017-10-01,2017-12-31,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,39100000.0
PTC Therapeutics Inc,PTCT,549300UJLWOIWFDGB318,0001070081,2017.0,Q4,2017-10-01,2017-12-31,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,0.09
PTC Therapeutics Inc,PTCT,549300UJLWOIWFDGB318,0001070081,2017.0,Q4,2017-10-01,2017-12-31,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,39183073.0
PTC Therapeutics Inc,PTCT,549300UJLWOIWFDGB318,0001070081,2017.0,Q4,2017-10-01,2017-12-31,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,0.09
PTC Therapeutics Inc,PTCT,549300UJLWOIWFDGB318,0001070081,2018.0,Q1,2018-01-01,2018-03-31,2019-05-02 17:13:44+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,56062000.0
PTC Therapeutics Inc,PTCT,549300UJLWOIWFDGB318,0001070081,2018.0,Q1,2018-01-01,2018-03-31,2019-05-02 17:13:44+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,56062000.0
PTC Therapeutics Inc,PTCT,549300UJLWOIWFDGB318,0001070081,2018.0,Q1,2018-01-01,2018-03-31,2019-05-02 17:13:44+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,3045000.0
PTC Therapeutics Inc,PTCT,549300UJLWOIWFDGB318,0001070081,2018.0,Q1,2018-01-01,2018-03-31,2019-05-02 17:13:44+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,3045000.0
PTC Therapeutics Inc,PTCT,549300UJLWOIWFDGB318,0001070081,2018.0,Q1,2018-01-01,2018-03-31,2019-05-02 17:13:44+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,53017000.0
PTC Therapeutics Inc,PTCT,549300UJLWOIWFDGB318,0001070081,2018.0,Q1,2018-01-01,2018-03-31,2019-05-02 17:13:44+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,32969000.0
PTC Therapeutics Inc,PTCT,549300UJLWOIWFDGB318,0001070081,2018.0,Q1,2018-01-01,2018-03-31,2019-05-02 17:13:44+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,31363000.0
PTC Therapeutics Inc,PTCT,549300UJLWOIWFDGB318,0001070081,2018.0,Q1,2018-01-01,2018-03-31,2019-05-02 17:13:44+00:00,totaloperatingexpenses,amortizationexpense,Amortization Expense,+,debit,usd,5428000.0
PTC Therapeutics Inc,PTCT,549300UJLWOIWFDGB318,0001070081,2018.0,Q1,2018-01-01,2018-03-31,2019-05-02 17:13:44+00:00,totaloperatingexpenses,otheroperatingexpenses,Other Operating Expenses / (Income),+,debit,usd,0.0
PTC Therapeutics Inc,PTCT,549300UJLWOIWFDGB318,0001070081,2018.0,Q1,2018-01-01,2018-03-31,2019-05-02 17:13:44+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,69760000.0
PTC Therapeutics Inc,PTCT,549300UJLWOIWFDGB318,0001070081,2018.0,Q1,2018-01-01,2018-03-31,2019-05-02 17:13:44+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-16743000.0
PTC Therapeutics Inc,PTCT,549300UJLWOIWFDGB318,0001070081,2018.0,Q1,2018-01-01,2018-03-31,2019-05-02 17:13:44+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,-3303000.0
PTC Therapeutics Inc,PTCT,549300UJLWOIWFDGB318,0001070081,2018.0,Q1,2018-01-01,2018-03-31,2019-05-02 17:13:44+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,1004000.0
PTC Therapeutics Inc,PTCT,549300UJLWOIWFDGB318,0001070081,2018.0,Q1,2018-01-01,2018-03-31,2019-05-02 17:13:44+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-2299000.0
PTC Therapeutics Inc,PTCT,549300UJLWOIWFDGB318,0001070081,2018.0,Q1,2018-01-01,2018-03-31,2019-05-02 17:13:44+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-19042000.0
PTC Therapeutics Inc,PTCT,549300UJLWOIWFDGB318,0001070081,2018.0,Q1,2018-01-01,2018-03-31,2019-05-02 17:13:44+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,221000.0
PTC Therapeutics Inc,PTCT,549300UJLWOIWFDGB318,0001070081,2018.0,Q1,2018-01-01,2018-03-31,2019-05-02 17:13:44+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-19263000.0
PTC Therapeutics Inc,PTCT,549300UJLWOIWFDGB318,0001070081,2018.0,Q1,2018-01-01,2018-03-31,2019-05-02 17:13:44+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-19263000.0
PTC Therapeutics Inc,PTCT,549300UJLWOIWFDGB318,0001070081,2018.0,Q1,2018-01-01,2018-03-31,2019-05-02 17:13:44+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-19263000.0
PTC Therapeutics Inc,PTCT,549300UJLWOIWFDGB318,0001070081,2018.0,Q1,2018-01-01,2018-03-31,2019-05-02 17:13:44+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,41900000.0
PTC Therapeutics Inc,PTCT,549300UJLWOIWFDGB318,0001070081,2018.0,Q1,2018-01-01,2018-03-31,2019-05-02 17:13:44+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.46
PTC Therapeutics Inc,PTCT,549300UJLWOIWFDGB318,0001070081,2018.0,Q1,2018-01-01,2018-03-31,2019-05-02 17:13:44+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,41900000.0
PTC Therapeutics Inc,PTCT,549300UJLWOIWFDGB318,0001070081,2018.0,Q1,2018-01-01,2018-03-31,2019-05-02 17:13:44+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.46
PTC Therapeutics Inc,PTCT,549300UJLWOIWFDGB318,0001070081,2018.0,Q1,2018-01-01,2018-03-31,2019-05-02 17:13:44+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,41626617.0
PTC Therapeutics Inc,PTCT,549300UJLWOIWFDGB318,0001070081,2018.0,Q1,2018-01-01,2018-03-31,2019-05-02 17:13:44+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.46
PTC Therapeutics Inc,PTCT,549300UJLWOIWFDGB318,0001070081,2018.0,Q2,2018-04-01,2018-06-30,2019-08-06 17:17:09+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,68743000.0
PTC Therapeutics Inc,PTCT,549300UJLWOIWFDGB318,0001070081,2018.0,Q2,2018-04-01,2018-06-30,2019-08-06 17:17:09+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,68743000.0
PTC Therapeutics Inc,PTCT,549300UJLWOIWFDGB318,0001070081,2018.0,Q2,2018-04-01,2018-06-30,2019-08-06 17:17:09+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,68743000.0
PTC Therapeutics Inc,PTCT,549300UJLWOIWFDGB318,0001070081,2018.0,Q2,2018-04-01,2018-06-30,2019-08-06 17:17:09+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,33545000.0
PTC Therapeutics Inc,PTCT,549300UJLWOIWFDGB318,0001070081,2018.0,Q2,2018-04-01,2018-06-30,2019-08-06 17:17:09+00:00,totaloperatingexpenses,marketingexpense,Marketing Expense,+,debit,usd,2572000.0
PTC Therapeutics Inc,PTCT,549300UJLWOIWFDGB318,0001070081,2018.0,Q2,2018-04-01,2018-06-30,2019-08-06 17:17:09+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,32607000.0
PTC Therapeutics Inc,PTCT,549300UJLWOIWFDGB318,0001070081,2018.0,Q2,2018-04-01,2018-06-30,2019-08-06 17:17:09+00:00,totaloperatingexpenses,amortizationexpense,Amortization Expense,+,debit,usd,5600000.0
PTC Therapeutics Inc,PTCT,549300UJLWOIWFDGB318,0001070081,2018.0,Q2,2018-04-01,2018-06-30,2019-08-06 17:17:09+00:00,totaloperatingexpenses,otheroperatingexpenses,Other Operating Expenses / (Income),+,debit,usd,-5574000.0
PTC Therapeutics Inc,PTCT,549300UJLWOIWFDGB318,0001070081,2018.0,Q2,2018-04-01,2018-06-30,2019-08-06 17:17:09+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,68750000.0
PTC Therapeutics Inc,PTCT,549300UJLWOIWFDGB318,0001070081,2018.0,Q2,2018-04-01,2018-06-30,2019-08-06 17:17:09+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-7000.0
PTC Therapeutics Inc,PTCT,549300UJLWOIWFDGB318,0001070081,2018.0,Q2,2018-04-01,2018-06-30,2019-08-06 17:17:09+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,-2884000.0
PTC Therapeutics Inc,PTCT,549300UJLWOIWFDGB318,0001070081,2018.0,Q2,2018-04-01,2018-06-30,2019-08-06 17:17:09+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-673000.0
PTC Therapeutics Inc,PTCT,549300UJLWOIWFDGB318,0001070081,2018.0,Q2,2018-04-01,2018-06-30,2019-08-06 17:17:09+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-3557000.0
PTC Therapeutics Inc,PTCT,549300UJLWOIWFDGB318,0001070081,2018.0,Q2,2018-04-01,2018-06-30,2019-08-06 17:17:09+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-3564000.0
PTC Therapeutics Inc,PTCT,549300UJLWOIWFDGB318,0001070081,2018.0,Q2,2018-04-01,2018-06-30,2019-08-06 17:17:09+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,389000.0
PTC Therapeutics Inc,PTCT,549300UJLWOIWFDGB318,0001070081,2018.0,Q2,2018-04-01,2018-06-30,2019-08-06 17:17:09+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-3953000.0
PTC Therapeutics Inc,PTCT,549300UJLWOIWFDGB318,0001070081,2018.0,Q2,2018-04-01,2018-06-30,2019-08-06 17:17:09+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-3953000.0
PTC Therapeutics Inc,PTCT,549300UJLWOIWFDGB318,0001070081,2018.0,Q2,2018-04-01,2018-06-30,2019-08-06 17:17:09+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-3953000.0
PTC Therapeutics Inc,PTCT,549300UJLWOIWFDGB318,0001070081,2018.0,Q2,2018-04-01,2018-06-30,2019-08-06 17:17:09+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,18800000.0
PTC Therapeutics Inc,PTCT,549300UJLWOIWFDGB318,0001070081,2018.0,Q2,2018-04-01,2018-06-30,2019-08-06 17:17:09+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.21
PTC Therapeutics Inc,PTCT,549300UJLWOIWFDGB318,0001070081,2018.0,Q2,2018-04-01,2018-06-30,2019-08-06 17:17:09+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,18800000.0
PTC Therapeutics Inc,PTCT,549300UJLWOIWFDGB318,0001070081,2018.0,Q2,2018-04-01,2018-06-30,2019-08-06 17:17:09+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.21
PTC Therapeutics Inc,PTCT,549300UJLWOIWFDGB318,0001070081,2018.0,Q2,2018-04-01,2018-06-30,2019-08-06 17:17:09+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,46137833.0
PTC Therapeutics Inc,PTCT,549300UJLWOIWFDGB318,0001070081,2018.0,Q2,2018-04-01,2018-06-30,2019-08-06 17:17:09+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.21
PTC Therapeutics Inc,PTCT,549300UJLWOIWFDGB318,0001070081,2018.0,Q3,2018-07-01,2018-09-30,2019-10-29 20:07:44+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,107182000.0
PTC Therapeutics Inc,PTCT,549300UJLWOIWFDGB318,0001070081,2018.0,Q3,2018-07-01,2018-09-30,2019-10-29 20:07:44+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,107182000.0
PTC Therapeutics Inc,PTCT,549300UJLWOIWFDGB318,0001070081,2018.0,Q3,2018-07-01,2018-09-30,2019-10-29 20:07:44+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,3292000.0
PTC Therapeutics Inc,PTCT,549300UJLWOIWFDGB318,0001070081,2018.0,Q3,2018-07-01,2018-09-30,2019-10-29 20:07:44+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,3292000.0
PTC Therapeutics Inc,PTCT,549300UJLWOIWFDGB318,0001070081,2018.0,Q3,2018-07-01,2018-09-30,2019-10-29 20:07:44+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,103890000.0
PTC Therapeutics Inc,PTCT,549300UJLWOIWFDGB318,0001070081,2018.0,Q3,2018-07-01,2018-09-30,2019-10-29 20:07:44+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,38368000.0
PTC Therapeutics Inc,PTCT,549300UJLWOIWFDGB318,0001070081,2018.0,Q3,2018-07-01,2018-09-30,2019-10-29 20:07:44+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,54368000.0
PTC Therapeutics Inc,PTCT,549300UJLWOIWFDGB318,0001070081,2018.0,Q3,2018-07-01,2018-09-30,2019-10-29 20:07:44+00:00,totaloperatingexpenses,amortizationexpense,Amortization Expense,+,debit,usd,5800000.0
PTC Therapeutics Inc,PTCT,549300UJLWOIWFDGB318,0001070081,2018.0,Q3,2018-07-01,2018-09-30,2019-10-29 20:07:44+00:00,totaloperatingexpenses,otheroperatingexpenses,Other Operating Expenses / (Income),+,debit,usd,53584000.0
PTC Therapeutics Inc,PTCT,549300UJLWOIWFDGB318,0001070081,2018.0,Q3,2018-07-01,2018-09-30,2019-10-29 20:07:44+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,152120000.0
PTC Therapeutics Inc,PTCT,549300UJLWOIWFDGB318,0001070081,2018.0,Q3,2018-07-01,2018-09-30,2019-10-29 20:07:44+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-48230000.0
PTC Therapeutics Inc,PTCT,549300UJLWOIWFDGB318,0001070081,2018.0,Q3,2018-07-01,2018-09-30,2019-10-29 20:07:44+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,-3118000.0
PTC Therapeutics Inc,PTCT,549300UJLWOIWFDGB318,0001070081,2018.0,Q3,2018-07-01,2018-09-30,2019-10-29 20:07:44+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,734000.0
PTC Therapeutics Inc,PTCT,549300UJLWOIWFDGB318,0001070081,2018.0,Q3,2018-07-01,2018-09-30,2019-10-29 20:07:44+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-2384000.0
PTC Therapeutics Inc,PTCT,549300UJLWOIWFDGB318,0001070081,2018.0,Q3,2018-07-01,2018-09-30,2019-10-29 20:07:44+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-50614000.0
PTC Therapeutics Inc,PTCT,549300UJLWOIWFDGB318,0001070081,2018.0,Q3,2018-07-01,2018-09-30,2019-10-29 20:07:44+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,355000.0
PTC Therapeutics Inc,PTCT,549300UJLWOIWFDGB318,0001070081,2018.0,Q3,2018-07-01,2018-09-30,2019-10-29 20:07:44+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-50969000.0
PTC Therapeutics Inc,PTCT,549300UJLWOIWFDGB318,0001070081,2018.0,Q3,2018-07-01,2018-09-30,2019-10-29 20:07:44+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-50969000.0
PTC Therapeutics Inc,PTCT,549300UJLWOIWFDGB318,0001070081,2018.0,Q3,2018-07-01,2018-09-30,2019-10-29 20:07:44+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-50969000.0
PTC Therapeutics Inc,PTCT,549300UJLWOIWFDGB318,0001070081,2018.0,Q3,2018-07-01,2018-09-30,2019-10-29 20:07:44+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,48100000.0
PTC Therapeutics Inc,PTCT,549300UJLWOIWFDGB318,0001070081,2018.0,Q3,2018-07-01,2018-09-30,2019-10-29 20:07:44+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-1.06
PTC Therapeutics Inc,PTCT,549300UJLWOIWFDGB318,0001070081,2018.0,Q3,2018-07-01,2018-09-30,2019-10-29 20:07:44+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,48100000.0
PTC Therapeutics Inc,PTCT,549300UJLWOIWFDGB318,0001070081,2018.0,Q3,2018-07-01,2018-09-30,2019-10-29 20:07:44+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-1.06
PTC Therapeutics Inc,PTCT,549300UJLWOIWFDGB318,0001070081,2018.0,Q3,2018-07-01,2018-09-30,2019-10-29 20:07:44+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,48096521.0
PTC Therapeutics Inc,PTCT,549300UJLWOIWFDGB318,0001070081,2018.0,Q3,2018-07-01,2018-09-30,2019-10-29 20:07:44+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-1.06
PTC Therapeutics Inc,PTCT,549300UJLWOIWFDGB318,0001070081,2018.0,Q4,2018-10-01,2018-12-31,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,32747000.0
PTC Therapeutics Inc,PTCT,549300UJLWOIWFDGB318,0001070081,2018.0,Q4,2018-10-01,2018-12-31,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,32747000.0
PTC Therapeutics Inc,PTCT,549300UJLWOIWFDGB318,0001070081,2018.0,Q4,2018-10-01,2018-12-31,,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,6333000.0
PTC Therapeutics Inc,PTCT,549300UJLWOIWFDGB318,0001070081,2018.0,Q4,2018-10-01,2018-12-31,,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,6333000.0
PTC Therapeutics Inc,PTCT,549300UJLWOIWFDGB318,0001070081,2018.0,Q4,2018-10-01,2018-12-31,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,26414000.0
PTC Therapeutics Inc,PTCT,549300UJLWOIWFDGB318,0001070081,2018.0,Q4,2018-10-01,2018-12-31,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,48666000.0
PTC Therapeutics Inc,PTCT,549300UJLWOIWFDGB318,0001070081,2018.0,Q4,2018-10-01,2018-12-31,,totaloperatingexpenses,marketingexpense,Marketing Expense,+,debit,usd,-2572000.0
PTC Therapeutics Inc,PTCT,549300UJLWOIWFDGB318,0001070081,2018.0,Q4,2018-10-01,2018-12-31,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,53646000.0
PTC Therapeutics Inc,PTCT,549300UJLWOIWFDGB318,0001070081,2018.0,Q4,2018-10-01,2018-12-31,,totaloperatingexpenses,amortizationexpense,Amortization Expense,+,debit,usd,6049000.0
PTC Therapeutics Inc,PTCT,549300UJLWOIWFDGB318,0001070081,2018.0,Q4,2018-10-01,2018-12-31,,totaloperatingexpenses,otheroperatingexpenses,Other Operating Expenses / (Income),+,debit,usd,-28670000.0
PTC Therapeutics Inc,PTCT,549300UJLWOIWFDGB318,0001070081,2018.0,Q4,2018-10-01,2018-12-31,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,77119000.0
PTC Therapeutics Inc,PTCT,549300UJLWOIWFDGB318,0001070081,2018.0,Q4,2018-10-01,2018-12-31,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-50705000.0
PTC Therapeutics Inc,PTCT,549300UJLWOIWFDGB318,0001070081,2018.0,Q4,2018-10-01,2018-12-31,,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,-3249000.0
PTC Therapeutics Inc,PTCT,549300UJLWOIWFDGB318,0001070081,2018.0,Q4,2018-10-01,2018-12-31,,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-936000.0
PTC Therapeutics Inc,PTCT,549300UJLWOIWFDGB318,0001070081,2018.0,Q4,2018-10-01,2018-12-31,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-4185000.0
PTC Therapeutics Inc,PTCT,549300UJLWOIWFDGB318,0001070081,2018.0,Q4,2018-10-01,2018-12-31,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-54890000.0
PTC Therapeutics Inc,PTCT,549300UJLWOIWFDGB318,0001070081,2018.0,Q4,2018-10-01,2018-12-31,,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,-994000.0
PTC Therapeutics Inc,PTCT,549300UJLWOIWFDGB318,0001070081,2018.0,Q4,2018-10-01,2018-12-31,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-53896000.0
PTC Therapeutics Inc,PTCT,549300UJLWOIWFDGB318,0001070081,2018.0,Q4,2018-10-01,2018-12-31,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-53896000.0
PTC Therapeutics Inc,PTCT,549300UJLWOIWFDGB318,0001070081,2018.0,Q4,2018-10-01,2018-12-31,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-53896000.0
PTC Therapeutics Inc,PTCT,549300UJLWOIWFDGB318,0001070081,2018.0,Q4,2018-10-01,2018-12-31,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,46600000.0
PTC Therapeutics Inc,PTCT,549300UJLWOIWFDGB318,0001070081,2018.0,Q4,2018-10-01,2018-12-31,,,basiceps,Basic Earnings per Share,=,,usdpershare,-1.02
PTC Therapeutics Inc,PTCT,549300UJLWOIWFDGB318,0001070081,2018.0,Q4,2018-10-01,2018-12-31,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,46600000.0
PTC Therapeutics Inc,PTCT,549300UJLWOIWFDGB318,0001070081,2018.0,Q4,2018-10-01,2018-12-31,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-1.02
PTC Therapeutics Inc,PTCT,549300UJLWOIWFDGB318,0001070081,2018.0,Q4,2018-10-01,2018-12-31,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,46576313.0
PTC Therapeutics Inc,PTCT,549300UJLWOIWFDGB318,0001070081,2018.0,Q4,2018-10-01,2018-12-31,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-1.02
PTC Therapeutics Inc,PTCT,549300UJLWOIWFDGB318,0001070081,2019.0,Q1,2019-01-01,2019-03-31,2020-04-30 16:41:46+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,53583000.0
PTC Therapeutics Inc,PTCT,549300UJLWOIWFDGB318,0001070081,2019.0,Q1,2019-01-01,2019-03-31,2020-04-30 16:41:46+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,53583000.0
PTC Therapeutics Inc,PTCT,549300UJLWOIWFDGB318,0001070081,2019.0,Q1,2019-01-01,2019-03-31,2020-04-30 16:41:46+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,2376000.0
PTC Therapeutics Inc,PTCT,549300UJLWOIWFDGB318,0001070081,2019.0,Q1,2019-01-01,2019-03-31,2020-04-30 16:41:46+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,2376000.0
PTC Therapeutics Inc,PTCT,549300UJLWOIWFDGB318,0001070081,2019.0,Q1,2019-01-01,2019-03-31,2020-04-30 16:41:46+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,51207000.0
PTC Therapeutics Inc,PTCT,549300UJLWOIWFDGB318,0001070081,2019.0,Q1,2019-01-01,2019-03-31,2020-04-30 16:41:46+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,40544000.0
PTC Therapeutics Inc,PTCT,549300UJLWOIWFDGB318,0001070081,2019.0,Q1,2019-01-01,2019-03-31,2020-04-30 16:41:46+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,52566000.0
PTC Therapeutics Inc,PTCT,549300UJLWOIWFDGB318,0001070081,2019.0,Q1,2019-01-01,2019-03-31,2020-04-30 16:41:46+00:00,totaloperatingexpenses,amortizationexpense,Amortization Expense,+,debit,usd,6077000.0
PTC Therapeutics Inc,PTCT,549300UJLWOIWFDGB318,0001070081,2019.0,Q1,2019-01-01,2019-03-31,2020-04-30 16:41:46+00:00,totaloperatingexpenses,otheroperatingexpenses,Other Operating Expenses / (Income),+,debit,usd,21160000.0
PTC Therapeutics Inc,PTCT,549300UJLWOIWFDGB318,0001070081,2019.0,Q1,2019-01-01,2019-03-31,2020-04-30 16:41:46+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,120347000.0
PTC Therapeutics Inc,PTCT,549300UJLWOIWFDGB318,0001070081,2019.0,Q1,2019-01-01,2019-03-31,2020-04-30 16:41:46+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-69140000.0
PTC Therapeutics Inc,PTCT,549300UJLWOIWFDGB318,0001070081,2019.0,Q1,2019-01-01,2019-03-31,2020-04-30 16:41:46+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,-2288000.0
PTC Therapeutics Inc,PTCT,549300UJLWOIWFDGB318,0001070081,2019.0,Q1,2019-01-01,2019-03-31,2020-04-30 16:41:46+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-109000.0
PTC Therapeutics Inc,PTCT,549300UJLWOIWFDGB318,0001070081,2019.0,Q1,2019-01-01,2019-03-31,2020-04-30 16:41:46+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-2397000.0
PTC Therapeutics Inc,PTCT,549300UJLWOIWFDGB318,0001070081,2019.0,Q1,2019-01-01,2019-03-31,2020-04-30 16:41:46+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-71537000.0
PTC Therapeutics Inc,PTCT,549300UJLWOIWFDGB318,0001070081,2019.0,Q1,2019-01-01,2019-03-31,2020-04-30 16:41:46+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,576000.0
PTC Therapeutics Inc,PTCT,549300UJLWOIWFDGB318,0001070081,2019.0,Q1,2019-01-01,2019-03-31,2020-04-30 16:41:46+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-72113000.0
PTC Therapeutics Inc,PTCT,549300UJLWOIWFDGB318,0001070081,2019.0,Q1,2019-01-01,2019-03-31,2020-04-30 16:41:46+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-72113000.0
PTC Therapeutics Inc,PTCT,549300UJLWOIWFDGB318,0001070081,2019.0,Q1,2019-01-01,2019-03-31,2020-04-30 16:41:46+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-72113000.0
PTC Therapeutics Inc,PTCT,549300UJLWOIWFDGB318,0001070081,2019.0,Q1,2019-01-01,2019-03-31,2020-04-30 16:41:46+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,55900000.0
PTC Therapeutics Inc,PTCT,549300UJLWOIWFDGB318,0001070081,2019.0,Q1,2019-01-01,2019-03-31,2020-04-30 16:41:46+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-1.29
PTC Therapeutics Inc,PTCT,549300UJLWOIWFDGB318,0001070081,2019.0,Q1,2019-01-01,2019-03-31,2020-04-30 16:41:46+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,55900000.0
PTC Therapeutics Inc,PTCT,549300UJLWOIWFDGB318,0001070081,2019.0,Q1,2019-01-01,2019-03-31,2020-04-30 16:41:46+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-1.29
PTC Therapeutics Inc,PTCT,549300UJLWOIWFDGB318,0001070081,2019.0,Q1,2019-01-01,2019-03-31,2020-04-30 16:41:46+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,55855111.0
PTC Therapeutics Inc,PTCT,549300UJLWOIWFDGB318,0001070081,2019.0,Q1,2019-01-01,2019-03-31,2020-04-30 16:41:46+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-1.29
PTC Therapeutics Inc,PTCT,549300UJLWOIWFDGB318,0001070081,2019.0,Q2,2019-04-01,2019-06-30,2019-08-06 17:17:09+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,85522000.0
PTC Therapeutics Inc,PTCT,549300UJLWOIWFDGB318,0001070081,2019.0,Q2,2019-04-01,2019-06-30,2019-08-06 17:17:09+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,85522000.0
PTC Therapeutics Inc,PTCT,549300UJLWOIWFDGB318,0001070081,2019.0,Q2,2019-04-01,2019-06-30,2019-08-06 17:17:09+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,85522000.0
PTC Therapeutics Inc,PTCT,549300UJLWOIWFDGB318,0001070081,2019.0,Q2,2019-04-01,2019-06-30,2019-08-06 17:17:09+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,49215000.0
PTC Therapeutics Inc,PTCT,549300UJLWOIWFDGB318,0001070081,2019.0,Q2,2019-04-01,2019-06-30,2019-08-06 17:17:09+00:00,totaloperatingexpenses,marketingexpense,Marketing Expense,+,debit,usd,3211000.0
PTC Therapeutics Inc,PTCT,549300UJLWOIWFDGB318,0001070081,2019.0,Q2,2019-04-01,2019-06-30,2019-08-06 17:17:09+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,59979000.0
PTC Therapeutics Inc,PTCT,549300UJLWOIWFDGB318,0001070081,2019.0,Q2,2019-04-01,2019-06-30,2019-08-06 17:17:09+00:00,totaloperatingexpenses,amortizationexpense,Amortization Expense,+,debit,usd,6600000.0
PTC Therapeutics Inc,PTCT,549300UJLWOIWFDGB318,0001070081,2019.0,Q2,2019-04-01,2019-06-30,2019-08-06 17:17:09+00:00,totaloperatingexpenses,otheroperatingexpenses,Other Operating Expenses / (Income),+,debit,usd,-38758000.0
PTC Therapeutics Inc,PTCT,549300UJLWOIWFDGB318,0001070081,2019.0,Q2,2019-04-01,2019-06-30,2019-08-06 17:17:09+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,80247000.0
PTC Therapeutics Inc,PTCT,549300UJLWOIWFDGB318,0001070081,2019.0,Q2,2019-04-01,2019-06-30,2019-08-06 17:17:09+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,5275000.0
PTC Therapeutics Inc,PTCT,549300UJLWOIWFDGB318,0001070081,2019.0,Q2,2019-04-01,2019-06-30,2019-08-06 17:17:09+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,-2074000.0
PTC Therapeutics Inc,PTCT,549300UJLWOIWFDGB318,0001070081,2019.0,Q2,2019-04-01,2019-06-30,2019-08-06 17:17:09+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-183000.0
PTC Therapeutics Inc,PTCT,549300UJLWOIWFDGB318,0001070081,2019.0,Q2,2019-04-01,2019-06-30,2019-08-06 17:17:09+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-2257000.0
PTC Therapeutics Inc,PTCT,549300UJLWOIWFDGB318,0001070081,2019.0,Q2,2019-04-01,2019-06-30,2019-08-06 17:17:09+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,3018000.0
PTC Therapeutics Inc,PTCT,549300UJLWOIWFDGB318,0001070081,2019.0,Q2,2019-04-01,2019-06-30,2019-08-06 17:17:09+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,774000.0
PTC Therapeutics Inc,PTCT,549300UJLWOIWFDGB318,0001070081,2019.0,Q2,2019-04-01,2019-06-30,2019-08-06 17:17:09+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,2244000.0
PTC Therapeutics Inc,PTCT,549300UJLWOIWFDGB318,0001070081,2019.0,Q2,2019-04-01,2019-06-30,2019-08-06 17:17:09+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,2244000.0
PTC Therapeutics Inc,PTCT,549300UJLWOIWFDGB318,0001070081,2019.0,Q2,2019-04-01,2019-06-30,2019-08-06 17:17:09+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,2244000.0
PTC Therapeutics Inc,PTCT,549300UJLWOIWFDGB318,0001070081,2019.0,Q2,2019-04-01,2019-06-30,2019-08-06 17:17:09+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,-3000000.0
PTC Therapeutics Inc,PTCT,549300UJLWOIWFDGB318,0001070081,2019.0,Q2,2019-04-01,2019-06-30,2019-08-06 17:17:09+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.75
PTC Therapeutics Inc,PTCT,549300UJLWOIWFDGB318,0001070081,2019.0,Q2,2019-04-01,2019-06-30,2019-08-06 17:17:09+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,-3000000.0
PTC Therapeutics Inc,PTCT,549300UJLWOIWFDGB318,0001070081,2019.0,Q2,2019-04-01,2019-06-30,2019-08-06 17:17:09+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.75
PTC Therapeutics Inc,PTCT,549300UJLWOIWFDGB318,0001070081,2019.0,Q2,2019-04-01,2019-06-30,2019-08-06 17:17:09+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,55912748.0
PTC Therapeutics Inc,PTCT,549300UJLWOIWFDGB318,0001070081,2019.0,Q2,2019-04-01,2019-06-30,2019-08-06 17:17:09+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.75
PTC Therapeutics Inc,PTCT,549300UJLWOIWFDGB318,0001070081,2019.0,Q3,2019-07-01,2019-09-30,2019-10-29 20:07:44+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,142832000.0
PTC Therapeutics Inc,PTCT,549300UJLWOIWFDGB318,0001070081,2019.0,Q3,2019-07-01,2019-09-30,2019-10-29 20:07:44+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,142832000.0
PTC Therapeutics Inc,PTCT,549300UJLWOIWFDGB318,0001070081,2019.0,Q3,2019-07-01,2019-09-30,2019-10-29 20:07:44+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,3006000.0
PTC Therapeutics Inc,PTCT,549300UJLWOIWFDGB318,0001070081,2019.0,Q3,2019-07-01,2019-09-30,2019-10-29 20:07:44+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,3006000.0
PTC Therapeutics Inc,PTCT,549300UJLWOIWFDGB318,0001070081,2019.0,Q3,2019-07-01,2019-09-30,2019-10-29 20:07:44+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,139826000.0
PTC Therapeutics Inc,PTCT,549300UJLWOIWFDGB318,0001070081,2019.0,Q3,2019-07-01,2019-09-30,2019-10-29 20:07:44+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,49284000.0
PTC Therapeutics Inc,PTCT,549300UJLWOIWFDGB318,0001070081,2019.0,Q3,2019-07-01,2019-09-30,2019-10-29 20:07:44+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,63076000.0
PTC Therapeutics Inc,PTCT,549300UJLWOIWFDGB318,0001070081,2019.0,Q3,2019-07-01,2019-09-30,2019-10-29 20:07:44+00:00,totaloperatingexpenses,amortizationexpense,Amortization Expense,+,debit,usd,7000000.0
PTC Therapeutics Inc,PTCT,549300UJLWOIWFDGB318,0001070081,2019.0,Q3,2019-07-01,2019-09-30,2019-10-29 20:07:44+00:00,totaloperatingexpenses,otheroperatingexpenses,Other Operating Expenses / (Income),+,debit,usd,80941000.0
PTC Therapeutics Inc,PTCT,549300UJLWOIWFDGB318,0001070081,2019.0,Q3,2019-07-01,2019-09-30,2019-10-29 20:07:44+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,200301000.0
PTC Therapeutics Inc,PTCT,549300UJLWOIWFDGB318,0001070081,2019.0,Q3,2019-07-01,2019-09-30,2019-10-29 20:07:44+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-60475000.0
PTC Therapeutics Inc,PTCT,549300UJLWOIWFDGB318,0001070081,2019.0,Q3,2019-07-01,2019-09-30,2019-10-29 20:07:44+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,-2666000.0
PTC Therapeutics Inc,PTCT,549300UJLWOIWFDGB318,0001070081,2019.0,Q3,2019-07-01,2019-09-30,2019-10-29 20:07:44+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,2800000.0
PTC Therapeutics Inc,PTCT,549300UJLWOIWFDGB318,0001070081,2019.0,Q3,2019-07-01,2019-09-30,2019-10-29 20:07:44+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,134000.0
PTC Therapeutics Inc,PTCT,549300UJLWOIWFDGB318,0001070081,2019.0,Q3,2019-07-01,2019-09-30,2019-10-29 20:07:44+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-60341000.0
PTC Therapeutics Inc,PTCT,549300UJLWOIWFDGB318,0001070081,2019.0,Q3,2019-07-01,2019-09-30,2019-10-29 20:07:44+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,-344000.0
PTC Therapeutics Inc,PTCT,549300UJLWOIWFDGB318,0001070081,2019.0,Q3,2019-07-01,2019-09-30,2019-10-29 20:07:44+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-59997000.0
PTC Therapeutics Inc,PTCT,549300UJLWOIWFDGB318,0001070081,2019.0,Q3,2019-07-01,2019-09-30,2019-10-29 20:07:44+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-59997000.0
PTC Therapeutics Inc,PTCT,549300UJLWOIWFDGB318,0001070081,2019.0,Q3,2019-07-01,2019-09-30,2019-10-29 20:07:44+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-59997000.0
PTC Therapeutics Inc,PTCT,549300UJLWOIWFDGB318,0001070081,2019.0,Q3,2019-07-01,2019-09-30,2019-10-29 20:07:44+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,56600000.0
PTC Therapeutics Inc,PTCT,549300UJLWOIWFDGB318,0001070081,2019.0,Q3,2019-07-01,2019-09-30,2019-10-29 20:07:44+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-1.06
PTC Therapeutics Inc,PTCT,549300UJLWOIWFDGB318,0001070081,2019.0,Q3,2019-07-01,2019-09-30,2019-10-29 20:07:44+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,56600000.0
PTC Therapeutics Inc,PTCT,549300UJLWOIWFDGB318,0001070081,2019.0,Q3,2019-07-01,2019-09-30,2019-10-29 20:07:44+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-1.06
PTC Therapeutics Inc,PTCT,549300UJLWOIWFDGB318,0001070081,2019.0,Q3,2019-07-01,2019-09-30,2019-10-29 20:07:44+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,56463528.0
PTC Therapeutics Inc,PTCT,549300UJLWOIWFDGB318,0001070081,2019.0,Q3,2019-07-01,2019-09-30,2019-10-29 20:07:44+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-1.06
PTC Therapeutics Inc,PTCT,549300UJLWOIWFDGB318,0001070081,2019.0,Q4,2019-10-01,2019-12-31,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,25043000.0
PTC Therapeutics Inc,PTCT,549300UJLWOIWFDGB318,0001070081,2019.0,Q4,2019-10-01,2019-12-31,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,25043000.0
PTC Therapeutics Inc,PTCT,549300UJLWOIWFDGB318,0001070081,2019.0,Q4,2019-10-01,2019-12-31,,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,6753000.0
PTC Therapeutics Inc,PTCT,549300UJLWOIWFDGB318,0001070081,2019.0,Q4,2019-10-01,2019-12-31,,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,6753000.0
PTC Therapeutics Inc,PTCT,549300UJLWOIWFDGB318,0001070081,2019.0,Q4,2019-10-01,2019-12-31,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,18290000.0
PTC Therapeutics Inc,PTCT,549300UJLWOIWFDGB318,0001070081,2019.0,Q4,2019-10-01,2019-12-31,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,63498000.0
PTC Therapeutics Inc,PTCT,549300UJLWOIWFDGB318,0001070081,2019.0,Q4,2019-10-01,2019-12-31,,totaloperatingexpenses,marketingexpense,Marketing Expense,+,debit,usd,-3211000.0
PTC Therapeutics Inc,PTCT,549300UJLWOIWFDGB318,0001070081,2019.0,Q4,2019-10-01,2019-12-31,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,81831000.0
PTC Therapeutics Inc,PTCT,549300UJLWOIWFDGB318,0001070081,2019.0,Q4,2019-10-01,2019-12-31,,totaloperatingexpenses,amortizationexpense,Amortization Expense,+,debit,usd,7973000.0
PTC Therapeutics Inc,PTCT,549300UJLWOIWFDGB318,0001070081,2019.0,Q4,2019-10-01,2019-12-31,,totaloperatingexpenses,otheroperatingexpenses,Other Operating Expenses / (Income),+,debit,usd,-14983000.0
PTC Therapeutics Inc,PTCT,549300UJLWOIWFDGB318,0001070081,2019.0,Q4,2019-10-01,2019-12-31,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,135108000.0
PTC Therapeutics Inc,PTCT,549300UJLWOIWFDGB318,0001070081,2019.0,Q4,2019-10-01,2019-12-31,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-116818000.0
PTC Therapeutics Inc,PTCT,549300UJLWOIWFDGB318,0001070081,2019.0,Q4,2019-10-01,2019-12-31,,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,-5463000.0
PTC Therapeutics Inc,PTCT,549300UJLWOIWFDGB318,0001070081,2019.0,Q4,2019-10-01,2019-12-31,,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,11215000.0
PTC Therapeutics Inc,PTCT,549300UJLWOIWFDGB318,0001070081,2019.0,Q4,2019-10-01,2019-12-31,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,5752000.0
PTC Therapeutics Inc,PTCT,549300UJLWOIWFDGB318,0001070081,2019.0,Q4,2019-10-01,2019-12-31,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-111066000.0
PTC Therapeutics Inc,PTCT,549300UJLWOIWFDGB318,0001070081,2019.0,Q4,2019-10-01,2019-12-31,,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,10644000.0
PTC Therapeutics Inc,PTCT,549300UJLWOIWFDGB318,0001070081,2019.0,Q4,2019-10-01,2019-12-31,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-121710000.0
PTC Therapeutics Inc,PTCT,549300UJLWOIWFDGB318,0001070081,2019.0,Q4,2019-10-01,2019-12-31,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-121710000.0
PTC Therapeutics Inc,PTCT,549300UJLWOIWFDGB318,0001070081,2019.0,Q4,2019-10-01,2019-12-31,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-121710000.0
PTC Therapeutics Inc,PTCT,549300UJLWOIWFDGB318,0001070081,2019.0,Q4,2019-10-01,2019-12-31,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,58900000.0
PTC Therapeutics Inc,PTCT,549300UJLWOIWFDGB318,0001070081,2019.0,Q4,2019-10-01,2019-12-31,,,basiceps,Basic Earnings per Share,=,,usdpershare,-1.17
PTC Therapeutics Inc,PTCT,549300UJLWOIWFDGB318,0001070081,2019.0,Q4,2019-10-01,2019-12-31,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,58900000.0
PTC Therapeutics Inc,PTCT,549300UJLWOIWFDGB318,0001070081,2019.0,Q4,2019-10-01,2019-12-31,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-1.17
PTC Therapeutics Inc,PTCT,549300UJLWOIWFDGB318,0001070081,2019.0,Q4,2019-10-01,2019-12-31,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,58863185.0
PTC Therapeutics Inc,PTCT,549300UJLWOIWFDGB318,0001070081,2019.0,Q4,2019-10-01,2019-12-31,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-1.17
